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ABSTRACT 
 
 
The vast majority of nanomaterials are chemically synthesized, a costly process, 
that is environmentally risky, and the produced nanoparticles are potentially toxic 
to patients. Nature-based nanomaterials, however, are proving to be much more 
biocompatible with lower environmental toxicity. Even though a variety of natural 
nanomaterials have been designed, fabrication technologies for the desired 
natural nanoparticles with reproducible quality, high productivity and low cost 
remain a challenge. My objective has been to establish strategies for the isolation, 
purification and characterization of nanoparticles using a production system 
based on green tea and fungus (Arthrobotrys oligospora) and also to develop 
new approaches for sustainable ―green manufacture‖ of gold nanoparticles for 
biomedical applications. First, an infusion-dialysis procedure to isolate of the tea 
nanoparticles (TNPs) from a green tea infusion was developed and validated. 
The TNPs are spherical with a diameter of 100-300 nm, and have a zeta 
potential of -26.52 mV at pH 7.0. The TNPs enhance secretion of the cytokines 
and the chemokines from mouse macrophages, suggesting a potential 
immunostimulatory effect. As a natural nanocarrier, the TNPs are able to form 
complexes with doxorubicin (DOX). The DOX-loaded TNPs increase cellular 
DOX uptake, leading to higher cytotoxicity in cancer cells. Second, a new 
isolation procedure was established to purify the fungal nanoparticles (FNPs) 
from A. oligospora, giving two purified FNP fractions. Both purified FNPs had a 
reduced diameter of 100-200 nm, with glycosaminoglycan as the main 
  vii 
constituent. The purified FNPs cause mild cytotoxicity by inducing apoptosis and 
regulating the cell cycle in multiple tumor cell lines and have an 
immunostimulatory effect. Additionally, the FNPs have an 
immunochemotherapeutic effect upon complexing with DOX against tumor cells. 
Third, a sustainable system for green manufacturing of gold nanoparticles was 
developed by using actively growing English ivy. The efficient uptake of the 
synthesized gold nanoparticles in mammalian cells provides the potential for 
biomedical applications. Finally, a simple one-step approach using dopamine, a 
monoamine neurotransmitter appearing naturally in the human brain, to 
synthesize highly branched gold nanoflowers (AuNFs) was developed. These 
AuNFs are highly biocompatible and provide high surface enhanced Roman 
scattering (SERS) performance.  
  viii 
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CHAPTER I  
INTRODUCTION  
 
 
Personalized medication and treatment are the optimal goals for disease 
treatment. This is particularly true for cancer therapy, due to the heterogeneity of 
cancer and its diverse causes. Individualized treatment could be achieved by 
developing an effective theranostic, defined as material that combines the 
modalities of the therapeutic medication and diagnostic imaging capability. [1]  
One huge advantage of theranostic is the avoidance of an adverse reaction 
between the diagnostics and the selectivity of the drug utilized in the treatment. 
Nanomaterials, which combine the imaging agents and the therapeutic drugs into 
molecules have the potential to be developed as the next generation of 
theranostics.  
 
The next generation drug delivery system: Nanoparticles 
Conventional therapeutic agents are distributed nonspecifically in the body where 
they affect both cancerous and normal cells. Thus the limiting dosage may not be 
optimal for treatment due to the excessive toxicities.  Nanoparticles, loaded with 
therapeutic drugs and modified for the tissue, cell and organelle targeting motifs, 
are able to target cancer cells using the unique pathophysiology of tumors, 
including cancerous cellular markers, organelle localization signals, and the 
enhanced permeability and retention effect of the tumor microenvironment. 
Additionally, nanoparticle carriers are able to improve the delivery of poorly 
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water-soluble drugs and enhance the circulation time of the drug in vivo to further 
reduce the dosage needed for treatment.  
 
Targeting: necessity or luxury? 
Current clinically approved nano-products are relative simple and lack of 
targeting motif. In fact, nearly 30 years after the first targeted l targeted 
liposomes is constructed. [2] Unfortunately, thus far this technology had a limited 
impact on human health. The reasons are complex and comprehensive. 
Targeted delivery of a therapeutic drug is a complicated procedure, involving the 
stability of the delivery particles, the mode of action of the drug and the efficiency 
of the site-specific delivery. In some cases, it is believed that targeting can cause 
anchoring of the delivery systems, reducing the efficiency of diffusion and tissue 
penetration. [3] However, dramatic molecular biology advances over the last 30 
years have expanded our understanding of the mechanisms involved, providing 
the means to develop new approaches to the design of drug delivery systems. 
The identification of specific molecular markers in different types of cancer cells 
provides new therapeutic targets, making it increasingly feasible to engineer a 
muti-functional and specific drug delivery system for therapeutic applications. 
This system is already being actively employed. Recently the phase I trial has 
been completed for CALAA-01[4], a transferrin-targeted particle delivering siRNA 
to reduce the expression of the M2 subunit of the ribonucleotide reductase (R2) 
for solid tumor therapy. 
 
  3 
Polymer-based Nanoparticles as drug delivery systems 
Several types of nanoparticles can be utilized in the design of a delivery system, 
including polymer-based drug carriers, polymeric nanoparticles, polymeric 
micelles, dendrimers, liposomes, viral nanoparticles, carbon nanotubes. Polymer-
based nanoparticles are derived from polymers such as albumin, chitosan, and 
heparin. They can be naturally used as material to deliver oligonucleotides, DNA, 
proteins and therapeutic drugs, including paclitaxel and doxorubicin. Doxorubicin, 
an anticancer drug, inhibits DNA topoisomerase II, an enzyme that is in both 
mitochondria and nucleus. DOX has been used in several studies as a 
therapeutic drug delivered into cancer cells. DOX has been successfully 
encapsulated into human serum albumin nanoparticles to treat anoikis-resistant 
breast cancer cells. The DOX-conjugated nanoparticles have proven to be 
significantly more cytotoxic to the breast cancer cells than free DOX. The 
conjugated nanoparticles have been delivered into the cells much more efficiently 
than the free DOX by avoiding the drug efflux pump system. [5] DOX has also 
been delivered by folate-conjugated P(NIPAAm- co -DMAAm- co -UA)- g -
cholesterol nanoparticles, which target the folate receptor of the cancerous cells 
enabling a more rapid entry into the nucleus. Based on this model, this study 
defines a mechanism for faster nuclear entry using folate as a cell specific 
targeting factor and undecenoic acid as a PH sensitive component which 
mediates a more efficient drug release and nucleus entry. [6] 
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The production of gold nanoparticles for biomedical applications 
Gold nanoparticles are of great interest in fields as diverse as electronics, 
coatings, photonics, surface-enhanced Raman scattering (SERS) and 
biotechnology. This is due to their unique properties, including size- and shape- 
based optical and electronic characteristics, their high surface area to volume 
ratio and their ability to be easily modified with ligands containing functional 
groups such as thiols and amines. [7] Additionally, gold nanoparticles are able to 
traverse through the vasculature, be localized in targeted areas, and can be 
attached to single strands of DNA nondestructively. [8] The use of gold 
nanoparticles to date suggests that they may be potentially useful in many 
biomedical applications. Considering their broad potential, the production of gold 
nanoparticles on a large-scale and in a controlled manner depending on the size, 
shape and crystallization has drawn significant attention in recent years. 
 
It is well known that the production of nanoparticles can be achieved by various 
methods. Although several chemical and physical strategies have been utilized to 
successfully produce pure and well-defined gold nanoparticles, these methods 
are toxic, expensive and/or potentially dangerous to the environment. A 
biologically synthesis of gold nanoparticles could be easily prove to be superior 
to the chemical and physical processes, due to the low cost, high efficacy, 
suitability for large-scale synthesis and low environmental impact. [9, 10] A 
variety of plants, fungus, and bacteria have been successfully used for rapid 
biological synthesis for gold nanoparticles. Plant extracts, such as lemongrass 
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(Cymbopogon flexuosus) [11], Aloe vera [12], geranium (Pelargonium graveolens) 
[13], tamarind (Tamarindus indica) [14], and English ivy [15] have been shown to 
have the ability to reduce Au(III) ions to Au(0). Microorganisms like bacteria, 
yeast and a number of species of fungus have also been employed, such as 
Fusarium oxysporum [16], Colletotrichum sp.[13], Rhodopseudomonas capsulate 
[17], and Trichothecium sp. [18]. The use of different plants and systems 
resulting in gold nanoparticlces with various shapes and sizes has led to the 
discovery of the role of reductases and reducing agents involved in the synthesis. 
Nitrate reductase from a fungus (Fusarium oxysporum) has been demonstrated 
to utilize NADPH as a reducing agent. [9] A variety of proteins, polyphenols and 
carbohydrates are involved in the synthesis of gold nanoparticles with different 
sizes and shapes. [9] These constituents present in plants and microorganisms 
may be useful in the synthesis of individualized nanoparticles. The involvement 
of these constituents in the mechanism of the synthesis needs further 
experimental examination. [9] 
 
Thesis Objectives 
A great deal of research has led to the development of chemically synthesized 
nanomaterials; however, a variety of natural nanomaterials, including viruses [19], 
lipoproteins[20],  diatoms nano-biosilica [21], ivy nanoparticles [22, 23], and 
fungal nanoparticles (A. Oligospora) [24], have recently drawn widespread 
attention. They have the advantages of being biocompatible, have low 
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environmental toxicity associated with production, and have promising medical 
applications. [22, 25, 26]  
 
Tea, one of the most popular beverages in the world, has numerous therapeutic 
effects. It has been implicated as a players in lowering blood pressure [27], 
decreasing blood coagulation [28], treating HIV [29], repairing oxidative 
damage[30, 31],  and cancer prevention and treatment. [32-35] Several studies 
have shown that the most active anticancer compounds in tea are polyphenols, 
such as (-)-epigallocatechin gallate (EGCG), (-)-epigallocatechin (EGC), and (+)-
gallocatechin (GC). [36-38] These polyphenols exhibit anticancer effects by 
affecting various genes involved in the regulation of the cell cycle, apoptosis, 
invasion, metastasis, and angiogenesis. [39, 40] In addition to the polyphenols, 
natural polysaccharides from tea have also drawn researchers’ attention due to 
their antitumor, immunostimulatory and antioxidant properties. [28, 41, 42] 
Interestingly, some naturally occurring nanoparticles with diameters of 200-300 
nm in black tea were reported by Groning et al in 1995; [43] however, not enough 
nanoparticles were isolated from black tea for further component analysis and 
specific biomedical characterization. This thesis elucidates a novel efficient 
method for purifying the tea nanoparticles to utilize their potential therapeutic 
properties for cancer therapy.  
 
Organic nanoparticles have shown promise in cancer treatment, due to their 
biocompatibility, biodegradation and multifunctional capacities. [44] Most reports 
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on natural organic nanoparticles are focusing on development in higher 
organisms, especially marine species and plants. Considering the rich biological 
diversity of the earth, natural organic nanoparticles may be produced in different 
forms and with different functions from unique origin. Investigation of 
nanoparticles in natural systems will not only help us to understand the roles of 
the nanoparticles in biological systems, but also provide us opportunities to 
develop these nanoparticles for specific biomedical applications. The discovery 
of new natural nanoparticles from A. Oligospora and the exploration of ―scalable 
green manufacturing‖ nanoparticles for cancer therapy is a step in this process. 
 
Gold nanoparticles have been utilized for many purposes. They have been 
proved to be especially effective for Surface Enhanced Raman Spectroscopy 
(SERS) [45], cancer diagnostics [46] and thermal therapy [47]. Several chemical 
and physical processes have been design in attempts to synthesize different 
sizes and shapes of gold nanoparticles. In order to reduce the use of toxic 
chemicals used in typical AuNP synthesis, active investigation for alternative 
synthesis methods are being employed using biological materials (proteins, 
polysaccharides, polyphenol, etc.) for green-synthesis of gold nanoparticles. 
While the use of plant extracts to synthesize AuNPs has been proposed, it has 
some serious drawbacks. Harvesting AuNPs from plant tissue introduces 
additional complexions due to the limited amount of AuNPs relative to the large 
plant biomass [48, 49], resulting in increased costs, and production delays. This 
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work offers a rapid and sustainable English ivy-based production system 
developed to synthesize gold nanoparticles for biomedical applications.  
 
Gold nanoflowers are specialized gold nanoparticles with multiple highly 
branched tips, which give the overall appearance of a flower. The 
nanomorphology of the highly tipped and branched often leads to the formation 
of sharp peaks and valleys, which are potential ―hot spots‖ for localized near-field 
enhancements. [45, 50, 51] The highly branched nanostructures can dramatically 
increase the ratio of total surface to volume. These factors lead to the 
enhancement of the Raman scattering on the highly branched gold 
nanostructures. [52, 53] Compared to smooth surfaces, highly branched surfaces 
(such as dendrites, multi-pods, and nanoflowers) have a greater potential for 
SERS based bioimaging and biosensing. While their potential usefulness has 
stimulated further research, the controllable synthesis of these unique 
nanostructures at a low cost remains a challenge. This thesis proposes a novel, 
one-step synthesis method to produce gold nanoflowers, using dopamine to 
insure a high SERS performance. 
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CHAPTER II  
TEA NANOPARTICLES FOR IMMUNOSTIMULATION AND 
CHEMO-DRUG DELIVERY IN CANCER TREATMENT 
 
  
  10 
Introduction 
 
Much research has contributed to the development of chemically synthesized 
nanomaterials; however, a variety of natural nanomaterials, such as viruses [19], 
lipoproteins [20], diatoms nano-biosilica [21], ivy nanoparticles [22, 23], and 
fungal nanoparticles (A. Oligospora) [24], have recently drawn researchers’ 
attention due to their promising biocompatibility, less environmental toxicity 
associated with their production, and their features desired in medicine. [22, 25, 
26] 
Tea is one of the most popular beverages in the world and has been linked to 
numerous therapeutic effects, including lowering blood pressure [27], decreasing 
blood coagulation [28], treating HIV [29], repairing oxidative damage[30, 31],  and 
cancer prevention and treatment[32-35]. Several studies have shown that the 
most active anticancer compounds in tea are polyphenols, such as (-)-
epigallocatechin gallate (EGCG), (-)-epigallocatechin (EGC), and (+)-
gallocatechin (GC) [36-38]. These polyphenols exhibit anticancer effects by 
affecting various genes involved in the regulation of the cell cycle, apoptosis, 
invasion, metastasis, and angiogenesis. [39, 40] In addition to the polyphenols, 
natural polysaccharides from tea have also drawn researchers’ attention due to 
their antitumor, immunostimulatory and antioxidant properties. [28, 41, 42] 
Interestingly, some natural nanoparticles with diameters of 200-300 nm in black 
tea were reported by Groning et al in 1995 [43]; however, they didn’t isolate 
enough nanopartiles from black tea for further component analysis and specific 
biomedical applications. Considering the success of other natural-based 
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nanoparticles for cancer chemotherapy and immunotherapy [24], we 
hypothesized that tea is an ideal source of highly biocompatible nanomaterials 
for different biomedical applications, especially for cancer therapy. Due to the 
traditional role of tea as a cancer preventing beverage and good biocompatibility, 
we believe that the development of nanoparticles from tea as a biomaterial may 
open a new avenue for cancer therapy.  
The goal of this study was to develop a fabrication method for isolation of natural 
nanoparticles from tea, and to explore their potential applications as a 
immunostimulatory agent and a nanocarrier for chemo-drug delivery in cancer 
therapy in vitro. For this purpose, an infusion-dialysis based procedure was 
developed to isolate spherical nanoparticles with diameters of 100-300 nm from 
green tea infusions (Figure 1). These TNPs were characterized by (atomic force 
microscopy) AFM, (scanning electron microscopy) SEM and (dynamic light 
scattering) DLS/ (electrophoretic light scattering) ELS. We have also conducted 
studies to quantitatively measure the concentration of protein, polysaccharide 
and other small molecules in the TNPs. The potential for the TNPs to be used as 
an immunostimulatory agent, and a natural drug nanocarrier for chemo-drug 
delivery to sensitive and resistant tumor cells was further evaluated through this 
study.  
  12 
 
Figure 1 Schematic of the infusion-dialysis based procedure for isolating the TNPs from 
green tea leaves for drug delivery.  
(A) Green tea infusion was prepared by hot DI water. (B) The syringe filter was used to remove 
big debris. (C) The dialysis tubing (MWCO=300KD) was used to remove small molecules in 
green tea infusion. (D) Isolation of the TNPs was determined by SEC-HPLC. (E) Sephadex G75 
column was used to separate the DOX-loaded TNPs and free DOX. (F) Isolated DOX-loaded 
TNPs were used for drug delivery. 
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Materials and Methods 
Materials 
 
Laoshan® green tea was purchased from China. (-) Epigallocatechin gallate 
(EGCG), caffeine, theobromine, 1,9-dimethyl-methylene blue (DMMB), 
chondroitin sulfate (CS), doxorubicin hydrochloride (DOX), HEPES, Sephadex 
G75 and phosphate buffered saline (PBS) were purchased from Sigma-Aldrich 
(St. Louis, MO). LysoTracker Green DND-26 and Hoechst 33342 were obtained 
from Invitrogen Life Technologies (Grand Island, NY). Fetal bovine serum, 
DMEM medium and RPMI 1640 medium were purchased from Mediatech 
(Manassas, VA). Penicillin (10000 units/ml)-streptomycin (10000 µg/ml) solution 
was obtained from MP biomedicals (Solon, OH). RAW 264.7 murine 
macrophages (TIB-71) and human non-small-cell lung cancer A549 cells (CCL-
185) were obtained from the American Type Culture Collection (Manassas, VA). 
The human breast tumor cell line MCF-7 and its resistant cell line MCF-7/ADR 
were obtained from the Frederick National Laboratory for Cancer Research 
(Frederick, MD). 
Preparation of Tea Nanoparticles (TNPs)   
 
Green tea infusions were made by steeping 15 g of dried green tea leaves in 200 
ml of boiling deionized water (DI water) for 20 minutes. The resulting hot tea 
infusion was then centrifuged at 5000 rpm for 10 min, and the supernatant was 
filtered through a 1 µm filter (Whatman Inc., Florham Park, NJ). The filtered 
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solution was then sonicated in a water-bath sonicater (model 750D, VWR) at 
room temperature for 30 min. The free small molecules, such as alkaloids, and 
polyphenols, were removed by dialysis using 300KD MWCO tubing against DI 
water for 3 days at room temperature. Size-exclusion high-performance liquid 
chromatography (SEC-HPLC) was used to further isolate the nanoparticles after 
dialysis. 250 µl of the dialyzed solution was loaded onto a SEC-HPLC column 
(Phenomenex® BIOSEP-SEC-S4000), and eluted with distilled water at 
1.0 ml/min of flow rate. The UV absorption at 280 nm was measured, and all 
fractions were collected.  
 
Determination of Chemical Components of TNPs  
 
The total amounts of polysaccharides were measured using the anthrone-sulfuric 
acid assay [54]. Briefly, the anthrone reagent was prepared freshly before 
analysis by dissolving 0.02 g of anthrone (0.2%) in 10 ml of concentrated sulfuric 
acid (98%). A standard glucose solution was prepared in PBS and serially diluted 
to 0, 15.625, 31.25, 62.5, 125, and 250 µg/ml. 0.2 ml of the glucose standards or 
tea nanoparticle solution (1mg/ml) was added to 0.5 ml of the freshly prepared 
0.2% anthrone-sulfuric acid. The mixture was stirred immediately and incubated 
in boiling water for 15 min. All samples were then put on ice for 5 min to stop the 
reaction. After keeping 10 min at room temperature, samples were placed in a 
96-well plate, and read at 620 nm in a microplate reader (Bio-Tek µQuant). The 
amount of proteins in the TNPs was determined using a bicinchoninic acid (BCA) 
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protein assay kit (Pierce) following the manufacturer’s instructions. Small 
molecules present in the TNPs, i.e. EGCG, caffeine and theobromine, were 
determined by the RP-HPLC method as reported previously.[55] Briefly, HPLC 
analysis was conducted on a Agilent 1200 series HPLC system equipped with 
DAD detector. The DAD acquisition wavelength was set from 200 to 400 nm, with 
output channel A at wavelength 280 nm and output channel B at 360 nm. 1 mg of 
the freeze-dried TNP sample was dissolved in 70% methanol solution, then 
incubated at room temperature for three hours and filtered through 0.22 µm filters 
(Carrigtwohill, Co. Cork, Ireland). 10µl of the filtered samples were then analyzed 
on an Eclipse XDB-C18 (4.6 mm ×150 mm, 5 µm) column. Gradient elution was 
performed by varying the proportion of solvent A (water-acetic acid, 97:3 v/v) to 
solvent B (methanol), with the flow rate of 1 ml/min. The mobile phase 
composition started at 100% solvent A for 1 min, followed by a linear increase of 
solvent B to 63% in 27 min, and then go back to the initial conditions in 2 min for 
the next run.  
Characterization of TNPs 
 
10µl of the TNP solution was air-dried on a silicon substrate or glass cover slip 
for SEM and AFM analysis to characterize the particle size and morphology of 
the TNPs. The SEM analysis was performed using a high resolution FE-SEM 
system (LEO 1525, Germany). AFM analysis (MFP-3D, Asylum Research, Santa 
Barbara, CA) was operated based on the software Igor Pro from Wavemetrics in 
AC mode, and an ACTA Probe from AppNano (Santa Clara, CA) at room 
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temperature. The samples were further analyzed by dynamic light scattering 
(DLS) and electrophoretic light scattering (ELS), using a Zetasizer Nano (Malvern 
Instruments Ltd, Worcestershine, UK), to determine the size distribution and zeta 
potential of the TNPs in solution. 
 
In Vitro Immunostimulatory Activity 
 
The mouse macrophage cell line, RAW 264.7, was incubated for 24 h in DMEM 
culture medium supplemented with 10% FBS and 1% penicillin-streptomycin at 
37°C in 5% CO2. The cells were then plated in 12-well plates at a density of 
5×106 cells/ml and cultured for 24 h. The TNP samples at the concentration of 
50µg/ml were added in each well. After incubation for 24 h, the supernatants 
were collected for ELISArray analysis. Mouse common cytokines and 
chemokines multi-analyte ELISArray kits (SABiosciences Corporation, Frederick, 
MD) were used to determine various cytokines (IL-1A, IL-1B, IL-2, IL-4, IL-6, IL-
10, IL-12, IL-17A, IFNγ, TNFα, G-CSF, and GM-CSF) and chemokines (RANTES, 
MCP-1, MIP-1a, MIP-1b, SDF-1, IP-10, MIG, Eotaxin, TARC, MDC, KC, and 
6Ckine) in the supernatants following the manufacturer’s instructions. 
Preparation and Characterization of Doxorubicin (DOX)-loaded TNPs 
 
The DOX-loaded TNPs were prepared by mixing DOX (0.3 mM) with the TNPs 
(1mg/ml) in HEPES buffer (20mM, pH=7.0) at room temperature for 3 hours. The 
DOX loaded into the TNPs were isolated from the free DOX in the solution by a 
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Sephadex G75 column method as previously reported.[56] The concentration of 
DOX loaded into the TNPs was determined by the DOX characteristic peak at 
480 nm. The absorbance was measured by a microplate reader (Bio-Tek 
µQuant). In order to evaluate the effect of pH on drug loading to the TNPs,  the 
DOX-loaded TNPs were prepared under different pH conditions (20mM HEPES 
buffer, pH=7.0, 5.5 and 3.5). After incubation at room temperature for 3 hours, 
samples were applied to the Sephadex G75 column, and eluted with 20 mM 
HEPES buffer under the corresponding pH values. Elution profiles of the DOX-
loaded TNPs (λ=480 nm) were plotted versus elution volumes. In order to 
characterize the hydrophobic interactions between DOX and the TNPs, the 
ultraviolet and visible (UV-Vis) spectra of the blank TNP solution, the DOX-
loaded TNP solution, and free DOX solution (with the same DOX concentration) 
were measured using a Thermo Scientific Evolution 600 UV-Visible 
spectrophotometer. Fluorescence spectra of the DOX-loaded TNPs and free 
DOX were then measured by using a spectrofluorimetry (LS-50B, Perkin Elmer) 
at the wavelength of 480nm (excitation). Fourier-transform infrared spectroscopy 
(FTIR) was finally performed to determine the possible binding effect of DOX and 
the TNPs. The DOX-loaded TNPs, and the blank TNPs were freeze-dried prior to 
FTIR analysis. Dry powders were mixed with potassium bromide, and 
transmission spectra were acquired with a Bruker Vertex 70 FT-IR spectrometer 
(Bruker Optics Inc, Billerica MA), equipped with a deuterated triglycine sulfate 
detector and controlled by the OPUS 6.5 software package. 
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In Vitro Release of DOX from TNPs 
 
In vitro release of DOX from the TNPs under acidic and neutral conditions 
(pH=5.0, 6.0 and 7.5) was evaluated. The release study was conducted in 
phosphate buffered saline (PBS, pH=7.5 and 6.0) and 0.1 M acetate buffer 
(pH=5.0) at room temperature with moderate shaking. Briefly, 1 ml of the DOX-
loaded TNPs or free DOX solution (with the same concentration of DOX= 0.1mM) 
was added to a dialysis membrane tube (MWCO= 12KD) and immersed in a 
glass container containing 30 ml of release buffers. 0.5 ml of the released 
solution was collected at different time intervals and replenished immediately with 
the same volume of the corresponding fresh medium. DOX release profiles were 
determined by a Synergy HT multi-detection microplate reader (Bio-Tek 
Instruments Inc., Winooski, VT) at 480 nm excitation and 590 nm emission.  
 Cellular Uptake and Confocal Microscopic Study of DOX-loaded TNPs 
 
The quantification of intracellular DOX uptake in cancer cells was evaluated by 
flow cytometry. In general, A549, MCF-7 and MCF-7/ADR cells were cultured in 
6-well plates at densities of 1×106 cells/ml, and incubated at 37°C in 5% CO2. 
The DOX-loaded TNPs  or free DOX solution at 10µM of DOX concentration 
were added into the wells and incubated at 37°C for 1h, 2h, and 3h, respectively. 
The media were aspirated and cells were rinsed with PBS for three times. Flow 
cytometry analysis was carried out on an Epics XL Analyzer (Beckman Coulter 
Inc., Brea, CA) by collecting 20000 events for each sample and measuring the 
cell associated fluorescence. Confocal laser scanning microscopy (CLSM) was 
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used to investigate intracellular DOX distribution in the above three cell lines 
treated with the DOX-loaded TNPs, and free DOX was used as a control. Briefly, 
the cells were seeded on cover slips with a density of 106 cells/ml in a 6-well 
plate and cultured at 37°C in 5% CO2 for 24 h. The cells were then treated with 
the DOX-loaded TNPs at 10 µM of DOX concentration for 1 h and 3h. To observe 
the intracellular distribution, endolysosome and nuclear markers, LysoTracker® 
green (100 nm) and Hoechst 33342 (4µM) were incubated with the cells for 30 
min prior to the confocal visualization. The cover slip was washed with PBS three 
times and then set on a microscope slide and examined by CLSM. 
In Vitro Cytotoxicity 
 
The cytotoxicity of the DOX-loaded TNPs against A549, MCF-7 and MCF-7/ADR 
was evaluated by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium 
bromide) assay.[57] Briefly, 5000 cells were plated in 96-well plates in 100 µl 
DMEM (for A549 cells) or RPMI 1640 (for MCF-7 and MCF-7/ADR cells) and 
supplemented with 10% fetal bovine serum (FBS) and 1.0 % penicillin-
streptomycin per well and incubated at 37 °C in 5% CO2 for 24 h to allow the 
cells to attach. The cells were then treated with different concentrations of the 
DOX-loaded TNPs for 48 h. Free DOX and the blank TNPs were used as 
controls. After the 48 h treatment, 10 μl of MTT solution (5 mg/ml in PBS; pH 7.4) 
was then added to each well and the plates were incubated for another 4 h. The 
cell culture media were removed and replaced with 100 µl DMSO. The 
absorbance was measured by a microplate reader (Bio-Tek µQuant) at 570 nm, 
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and the average IC50 (the dose having 50% cell inhibition) value was determined 
by cell survival plots using the ―DoseResp‖ function in OriginPro 8.0.  
Statistical Analysis 
 
Values were presented as mean ± standard deviation (S.D.) of at least three 
independent measurements. Statistical significance was tested by one-way 
ANOVA followed by a Student's t test for multiple comparison tests. A p value of 
<0.05 was considered statistically significant. 
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Results and Discussion 
Spherical nanoparticles isolated from tea infusion  
 
An infusion-dialysis based procedure was developed to isolate nanoparticles 
from tea infusion (Figure 1A-B). To remove the large debris, the tea infusion was 
centrifuged at 5000 rpm for 10 min. The supernatant was then filtered through a 
1µm filter, and dialyzed to remove any compounds with MW of less than 300KD. 
To further validate the infusion-dialysis based procedure, size exclusion 
chromatography-high performance liquid chromatography (SEC-HPLC) analysis 
was utilized for separating the tea infusions before and after the dialysis. As 
shown in Figure 1, there were multiple UV peaks at 280 nm that occurred at 
different elution times before the dialysis (Figure 1B), while only one well-defined 
peak was detected at 0-10 min after the dialysis (Figure 1D). The single peak in 
the SEC-HPLC profile indicated that the dialyzed sample was more homogenous 
and likely contained a narrow range of nanoparticles.[58] To determine if the 
nanoparticles could be found in the fraction collected from this peak, the sample 
was scanned using AFM and SEM. As hypothesized, AFM images (Figure 2A-B) 
showed clearly that abundant spherical nanoparticles with diameters in the range 
of 100-300 nm were observed. Similarly, SEM analysis revealed the presence of 
abundant spherical nanoparticles in the range of 50-200 nm in diameter (Figure 
2C). To determine the size distribution of the TNPs in solution, DLS was 
conducted on the TNP containing fraction. Results in Figure 3 and Table 1, the 
tea nanoparticles showed a relatively broad distribution of size with a mean 
hydrodynamic diameter of 318.3 nm. 
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Figure 2 AFM (A-B) and SEM (C) images of the TNPs obtained from the green tea infusion. 
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Figure 3 The size distribution of the TNPs at pH= 7.0 (A), and the DOX-loaded TNPs at pH= 
7.0 (B), pH= 5.5 (C), and pH= 3.5 (D) in suspension measured by DLS. 
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Table 1 Characteristics of the TNPs and the DOX-loaded TNPs. 
Samples Diameter  
[nm] 
PDI Zeta 
potential 
[mV] 
Protein  
[µg/mg] 
Polysaccharide  
[µg/mg] 
TNPs 
(pH=7.0) 
318.3 0.324 -26.52±2.21 453.36±7.71 189.12±9.03 
DOX-loaded 
TNPs 
(pH=7.0) 
287.0 0.305 -6.34±1.49 -- -- 
DOX-loaded 
TNPs 
(pH=5.5) 
301.6 0.292 -8.30±1.35 -- -- 
DOX-loaded 
TNPs 
(pH=3.5) 
271.9 0.275 -9.15±0.33 -- -- 
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Further, the surface charge potential of the TNPs was analyzed using ELS. The 
TNPs were found to be -26.52±2.21 mV at pH 7.0. The results from this analysis 
clearly demonstrated that the method developed for isolating nanoparticles from 
green tea infusion was effective, leading to a stable population of the TNPs. At 
present, it is not well understood how the nanoparticles are formed in tea, and 
what roles they play in the growth and development processes of green tea. 
However, several studies have reported the observation and tentative 
components of the nanoparticles in black tea.[43, 59] In 1995, a study reported 
nanoparticles in aqueous black tea extracts formed on cooling.[43] The black tea 
nanoparticles showed particle size of about 200-300 nm, similar to the 
nanoparticles isolated from green tea in this study. A study in 1963 [59] proposed 
that the main components in black tea nanoparticles were caffeine, theaflavins 
and the thearubingins; however, there was no direct evidence to validate these 
tentative components in their paper.[43]  Due to the use of the infusion-dialysis 
based procedure for the TNP isolation in our study, small molecules not 
complexed with the TNPs were removed, thus several bioactive phytochemicals 
in green tea were not expected to be contained in the TNP fraction. In order to 
validate this assumption, we have analyzed the concentrations of three common 
phytochemicals from green tea, including (-)-epigallocatechin gallate (EGCG), 
caffeine and theobromine, using the reversed phase HPLC (RP-HPLC) method. 
To effectively solubilize these small molecules from the TNPs, a single extraction 
with methanol was used[60]. As shown in Figure 4A-C, the UV 280nm  
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Figure 4 HPLC chromatograms of EGCG (A), caffeine (B), theobromine (C) as standards, 
and isolated TNPs (D) at 280 nm. 
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peaks of 10 µg/ml EGCG, caffeine and theobromine standards appeared at 
respective retention time of 11.59, 12.66 and 7.68 min. However, no peak from 
EGCG, caffeine and theobromine was observed in the TNP fraction, indicating 
that they were not present in the TNPs (Figure 4D). To further investigate the 
possible chemical components of the TNPs, we detected the concentrations of 
two common macromolecules (i.e., protein and polysaccharide) in the TNPs, 
measured by the BCA protein assay and anthrone-sulfuric acid method, 
respectively. As shown in Table 1, there were about 453.36 µg proteins and 
189.12 µg polysaccharides in 1 mg TNPs. According to previous studies, the 
polysaccharides from green tea were believed to be a typical 
heteropolysaccharide and consisted of mannose, ribose, rhamnose, glucuronic 
acid, galacturonic acid, glucose, xylose, galactose and arabinose [61], and some 
acidic polysaccharides were reported to be bound to protein [62]. Considering the 
excellent biocompatibility of green tea, although there is no complete dissection 
for all components in these new natural nanoparticles, the two confirmed 
components, polysaccharide and protein, can still provide an opportunity for us to 
explore the potential biomedical application of the TNPs (Figure 1E-F). 
 
Immunostimulatory effect of TNPs on RAW 264.7 mouse macrophages 
 
As is well-known,polysaccharides isolated from a wide range of plants, including 
higher plants, mushrooms, lichens and algae often have macrophage modulatory 
effects [63], and thus are promising candidates for therapeutics in 
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immunomodulatory, anti-tumor and wound healing applications [63, 64]. 
Polysaccharides from green tea have also been reported to possess 
immunological and anti-cancer properties both in vivo and in vitro [65, 66]. 
Inspired by these studies, we have evaluated the potential immunological effect 
of the TNPs in vitro. It is well-known that macrophages as the first line of host 
defense can function as antigen-presenting cells, and interact with other immune 
cells to modulate the immune response [63]. For cancer treatment, macrophages 
mediate tumor cytotoxicity via the production of various cytokines and other 
immune factors [67]. Testing the secretion of cytokines and chemokines from 
macrophages induced by potential immunostimulatory substances is a common 
approach to evaluate their immunostimulatory activity [68]. Using a murine-
derived macrophages RAW 264.7, we first tested 12-cytokine profiles, including 
IL-1A, IL-1B, IL-2, IL-4, IL-6, IL-10, IL-12, IL-17A, IFN-γ, TNF-α, G-CSF, and GM-
CSF, after treatment with 50µg/ml of the TNPs.  It is noteworthy that the levels of 
IL-6 (p<0.01), TNF-α (p<0.05) and G-CSF (p<0.01) were significantly increased 
after incubation of RAW 264.7 macrophages with the TNPs for 24 h as indicated 
by ELISArray (Figure 5A). TNF-α is a multifunctional cytokine that plays a key 
role in apoptosis, cell survival, inflammation and immunity. The importance of 
TNF-α in the immune system mainly stems from its ability to interact with different 
receptors, and then activate several signal transduction pathways, leading to the 
diverse functions, especially its immunostimulatory effect [69]. It has also been 
reported that TNF-α could act synergistically with other drugs at the molecular 
level to trigger the apoptosis and dissociation of tumor vascular endothelial cells 
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in cancer treatment.[70, 71] IL-6 has been recognized as an important host 
defense molecule that can affect tumor cells.[72] It also plays key roles in T-cell-
mediated immune responses, acting as a cofactor for T-cell proliferation.[73] G-
CSF has a variety of functions including the induction of proliferation, survival 
and differentiation of hematopoietic cells, as well as mobilization of bone marrow 
cells.[74] Because G-CSF can stimulate the differentiation of bone marrow stem 
cells, and promote the mobilization of hematopoietic precursor cells from the 
bone marrow into the bloodstream,[75] it has been reported to be used in many 
cancer patients to prevent and counterbalance chemotherapy-associated 
neutropenia.[76] In addition to the ability of the TNPs to stimulate IL-6, TNF-α, 
and G-CSF secretion, secretion profiles of the 12 chemokines, including 
RANTES, MCP-1, MIP-1a, MIP-1b, SDF-1, IP-10, MIG, Eotaxin, TARC, MDC, 
KC, and 6Ckine, were also analyzed. As shown in Figure 5B, significantly 
enhanced productions of RANTES (p<0.01), IP-10 (p<0.05) and MDC (p<0.01) 
were observed after incubation with the TNPs. The primary function of 
chemokines is chemoattraction and activation of specific leucocytes in various 
immune-inflammatory responses. Besides their actions on haematopoietic cells, 
chemokines were also demonstrated to induce distinct effects in stromal and 
solid tumour cells.[77] RANTES was the first chemokine reported to mediate anti-
tumor immunity in part through direct T cell effector recruitment.[78, 79] IP-10 
has been suggested to exhibit anti-tumor and anti-metastatic properties, and its 
immunological properties appear to be dependent on the attraction of monocytes  
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Figure 5 Effects of the TNPs (50µg/ml) on in vitro secretion of cytokines 
Effects of TNPs (50ug/ml) on in vitro secretion of cytokines (IL-1A,IL-1B, IL-2, IL-4, IL-6, IL-10, IL-
12, IL-17A, IFN-γ, TNF-α, G-CSF, and GM-CSF), and chemokines (RANTES, MCP-1, MIP-1a, 
MIP-1b, SDF-1, IP-10, MIG, Eotaxin, TARC, MDC, KC, and 6Ckine) by RAW264.7 macrophage 
cells. (A) Inductions of cytokines (IL-6, TNF-α and G-CSF) were determined by ELISArray in 
supernatants of the cells cultured for 24 h. (B) Secretion of chemokines (RANTES, IP-10 and 
MDC) were determined by ELISArray in supernatants of the cells cultured for 24 h. The values 
stand for means ± SD obtained from three independent experiments. *P<0.05 and †P< 0.01, as 
compared with the controls. 
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and T lymphocytes.[80] Moreover, IP-10 can induce tumor regression and 
immunity to subsequent tumor challenge.[77, 81] There is also in vivo evidence 
indicating that MDC is identified in diversion of effective antitumor responses.[82] 
These evidences indicate that the TNPs may exert various beneficial 
pharmacological effects, especially antitumor effect, via their ability to modulate 
macrophage immune function. 
DOX loading in TNPs via electrostatic and hydrophobic interactions 
 
As mentioned above, the TNPs have a surface potential of ~-26mV at pH7.0, 
which is a desirable property for binding cationic chemo-drugs. To test the 
potential of the TNPs as a nanocarrier, complexation of the isolated TNPs with 
the cationic cancer theraputic DOX was conducted. Typically, there are two ways 
to load DOX onto nanoparticles: electrostatic binding of cationic DOX to 
nanoparticles, and entrapment of the neutral DOX with hydrophobic groups.[83] 
Considering the negative surface potential of the TNPs at the physiological pH, 
the complexation of DOX with the TNPs through electrostatic interactions was 
performed. For this purpose, 0.3mM of DOX was mixed with 1mg/ml of the TNPs 
in 20mM HEPES buffer (pH 7.0) and incubated for 3 hours at room temperature. 
After loading the mixture onto a Sephadex G75 column, the DOX-loaded TNPs 
were collected from the first peak of the elution profile.[56] As shown in Figure 
6A. the first peak (5-10 ml) stands for the DOX-loaded TNPs, while the second 
peak (11-20 ml) represents the free DOX.[56] The association efficiency of DOX 
loaded onto the TNPs was 46% at pH 7.0. The average diameter of the DOX-
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loaded TNPs was similar to the blank TNPs; however the DOX-loaded TNPs 
showed a lower zeta potential (-6.34 mV) as compared with that of blank TNPs (-
26.52 mV) (Table 1). This decrease in zeta potential suggests that the positively 
charged DOX molecules may be adsorbed onto the negatively charged TNPs 
through electrostatic interactions. To verify this hypothesis, 1mg/ml of TNP 
solution was mixed with 0.3mM of DOX at various pH (7.0, 5.5 and 3.5). The 
loading profiles of DOX to the TNPs under different pH values were recorded by 
separating the DOX-loaded TNPs from free DOX using G75 column. As shown in 
Figure 6A, compared with pH 7.0, there was a slight decrease for the amount of 
DOX loaded onto the TNPs at pH 5.5, while when the pH was adjusted to 3.5, 
the area of the first peak decreased dramatically and the second peak increased, 
indicating that DOX was not efficiently loaded. While a clear difference in loading 
was observed at pH 3.5, the average diameters and size distributions of the 
DOX-loaded TNPs under different pH did not show a clear difference (Figure 3). 
Apart from the electrostatic interaction between DOX and the TNPs, hydrophobic 
interactions may also contribute to the formation of the DOX-loaded TNPs. As 
shown in Figure 6B-C, compared to free DOX, a significant DOX fluorescence 
quenching effect in the DOX-loaded TNP sample was observed, while there was 
no significant decrease in UV absorption for the DOX-loaded TNPs at the same 
DOX concentration. This data suggests that hydrophobic interactions may lead to 
complexation of DOX to the TNPs, and the resulting quenching effect may be 
due to the dense packing of the DOX molecules on the nanoparticle surface.[84] 
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Figure 6 Characterization of the DOX-loaded TNPs.  
(A) Loading profiles of DOX to TNPs under various pH conditions: acidic (pH= 3.5 and 5.5), and 
neutral (pH= 7.0). With the decrease of the pH value, the binding between the TNPs and DOX 
decreased. (B) UV-Vis absorbance spectra of DOX (blue), the TNPs (black), and the DOX-loaded 
TNPs (red) solution. Characteristic DOX absorption peak is at 480nm. (C) Fluorescence spectra 
of free DOX and the DOX-loaded TNPs solutions with the same DOX concentration (5 µM) under 
480 nm excitation. A quenching effect of DOX fluorescence was observed for the DOX-loaded 
TNPs. (D) Release profiles of DOX from the TNPs under different pH conditions (pH=5.0, pH=6.0 
and pH=7.5). Free DOX was used as a control.  
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To further evaluate whether covalent bonds were available between the TNPs 
and DOX, the DOX-loaded TNPs were characterized by FTIR, using free DOX 
and the TNPs as controls. Comparing the FTIR spectrum of the DOX-loaded 
TNPs with those of the blank TNPs and free DOX, there were additional 
absorption bands at ~1734 and 1289 cm-1 corresponding to the C-O-CH3 
stretching bands of DOX (Figure 7), indicating DOX was successfully loaded 
onto the TNPs. No other new peaks appeared or shifted, suggesting that there 
was no covalent bonding between DOX and the TNPs.  
pH-responsive DOX release from TNPs 
 
In order to evaluate the potential of the TNPs as a nanocarrier for cancer 
treatment, DOX release behavior from the DOX-loaded TNPs was evaluated at 
neutral and acidic pH by using buffers with varying pH values (pH=5.0, 6.0 and 
7.5). As shown in Figure 6D, more than 90% of free DOX was released under 
the neutral condition after 6 hours, while the release of DOX from the TNPs 
under different pH values reached a plateau after 25 hours. The sustained DOX 
release from the TNPs demonstrated that the release process is a pH-responsive 
release at various pH conditions. During the first 10 hours of the first-order 
release curve, there was no significant difference in the cumulative release of 
DOX from the TNPs at both neutral and acidic pH, presumably because the 
hydrophobic interaction dominated the stability of the DOX-loaded TNPs, when 
more DOX was associated with the nanoparticles [85]. 
 
  35 
 
Figure 7 FTIR spectra of DOX (black), the TNPs (red), and the DOX-loaded TNPs (blue). 
The absorption bands at ~1734 and ~1289 cm-1 correspond to the C-O-CH3 stretching 
bands of DOX. The band around 1652 cm-1 and 1223 cm-1 may be due to the C=O and 
CN stretch vibrations of amide, which comes from proteins and polysaccharides of the 
TNPs. For the spectrum of the DOX-loaded TNPs, the bands all come from DOX and the 
TNPs, and no other new peaks appeared or shifted, suggesting that there is no covalent 
bonding between DOX and the TNPs. 
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While after 10 hours, the cumulative release of DOX from the TNPs was 
significantly higher in the acidic condition compared with the neutral condition. 
About 88% of DOX was released from the TNPs under the acidic condition at pH 
5.0, while around 80% and 70% of DOX was released under pH 6.0 and 7.5 after 
25 hours. It likely indicated that the dominant driving force maintaining the 
stability of the DOX-loaded TNPs was gradually shifted to the electrostatic 
interaction between DOX and the TNPs, due to the fact that a majority of  DOX 
(~70%) released and less DOX remained in the TNPs.[85] Since acidic 
conditions could potentially cause a decrease in the negative charges on the 
TNPs, the binding between the TNPs and DOX was weakening, and more DOX 
was disassociated from the TNPs with the decrease of the pH value. The pH-
responsive drug release behavior is regarded as a favorable property for in vivo 
antitumor applications.[86] Since only small amounts of DOX release in the blood 
circulation (pH=7.4), more active drug could be released after reaching the target, 
as a result of the lower pH in the tumor tissue or in the endosomes (pH=~ 5) after 
entering into cells via endocytosis.[86] Thus, the pH-responsive release property 
of DOX from the TNPs would probably make them to be used as an effective 
nanocarrier for drug delivery in cancer treatment. 
 
TNPs facilitate intracellular DOX delivery in sensitive and resistant tumor 
cells 
 
The quantitative determination of DOX uptake in cancer cells was conducted by 
flow cytometry. Two sensitive tumor cell lines, A549 human lung cancer cells and 
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MCF-7 breast cancer cells, were incubated with the DOX-loaded TNPs at a DOX 
concentration of 10 µM for1 h, 2 h and 3 h. The cell-associated fluorescence 
intensity, which was directly proportional to the amount of DOX internalized in 
cells, was then measured.[87] Figure 8A-F show the flow cytometry histograms 
of DOX fluorescence from both cells incubated with the DOX-loaded TNPs, free 
DOX and the blank TNPs. For all time points, the treatment of the DOX-loaded 
TNPs showed a significant increase in the level of DOX uptake compared with 
free DOX. To test if the TNPs could also increase the uptake and accumulation 
of DOX in drug-resistant cancer cells, the uptake of the DOX-loaded TNPs and 
free DOX by resistant MCF-7/ADR breast cancer cells was evaluated. As shown 
in Figure 8G-J, compared with free DOX, the intracellular accumulation of DOX 
increased from 1h to 3h in the resistant MCF-7/ADR cells treated with the DOX- 
loaded TNPs. The above data suggested that the DOX-loaded TNPs could 
provide an alternative treatment option for drug-resistant tumors.[88] To assess 
the intracellular distribution of the DOX-loaded TNPs, we incubated both 
sensitive cell lines with the DOX-loaded TNPs at a DOX concentration of 10 µM 
for 1h and 3 h, and then conducted confocal laser scanning microscopy (CLSM). 
The nucleus and endolysosomes were labeled with the nucleus-selective dye 
(Hoechst 33342, blue), and acidic endolysosomes-selective dye (LysoTracker®, 
green DND-26), respectively. As shown in Figure 9, the intracellular distribution 
of the DOX-loaded TNPs was different from that of free DOX in both cells. After 
1h incubation, treatment of both cells with free DOX resulted in weak DOX 
fluorescence in the cytoplasm. 
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Figure 8  Quantitative flow cytometry analysis for intracellular uptake of free DOX and the 
DOX-loaded TNPs 
Quantitative flow cytometry analysis for intracellular uptake of free DOX and the DOX-loaded 
TNPs in A549 (A-C), MCF-7(D-F) and MCF-7/ADR (G-J) cells at different time points (1h, 2h and 
3h). All cells were treated with the DOX-loaded TNPs and free DOX at the same DOX 
concentration of 10 µM for different time intervals. 
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Figure 9 CLSM images of the intracellular distributions of the DOX-loaded TNPs in A549 
and MCF-7 cells. 
CLSM images of the intracellular distributions of the DOX-loaded TNPs and free DOX with the 
same DOX concentration (10µM) in sensitive human lung cancer A549 and human breast cancer 
MCF-7 cells for different time incubation (1 h and 3 h). The cells were stained with Lysotracker® 
green DND-26 (green) and Hoechst 33342 (blue). The pink color shows the localization of DOX 
(red) in nucleus (blue), and the yellow color indicates the localization of DOX (red) in 
endosomes/lysosomes (green). The scale bars represent 10 μm.   
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However, for the DOX-loaded TNPs treatment, stronger DOX fluorescence could 
be detected in the cytoplasm in both cells. Differences in intracellular distribution 
of the DOX-loaded TNPs and free DOX in both cells were also obtained after 3h 
treatment. The intense DOX fluorescence was visualized in both cytoplasm, and 
the nucleus for the treatment of the DOX-loaded TNPs, while in the treatment of 
free DOX, it appeared that there was less DOX fluorescence in the cytoplasm 
and a smaller amount of DOX fluorescence in the nucleus. These results are 
consistent with the cellular uptake investigated by flow cytometry in Figure 8A-F. 
In terms of DOX localization in both cells, a large fraction of the DOX-loaded 
TNPs was found to be entrapped in endolysosomes after 1 h incubation, while 
more DOX fluorescence was observed to be out of endolysosomes and localized 
in cytoplasm and nucleus after 3h incubation (Figure 9). Since the enhanced 
uptake of the DOX-loaded TNPs was also observed in resistant cells by flow 
cytometry, we visualized their intracellular distribution in MCF-7/ADR cells to 
further assess the potential of the TNPs for cancer treatment. As shown in 
Figure 10, after 1h treatment, small amount of DOX was localized in the 
cytoplasm of MCF-7/ADR cells; however, more DOX fluorescence accumulated 
in the discrete cytoplasm area was observed, when the MCF-7/ADR cells were 
treated with the DOX-loaded TNPs. For 3h treatment, most free DOX 
accumulated in discrete granules in the cytoplasm, and a little was observed in 
nucleus.  
In case of the DOX-loaded TNPs, significant increase of intracellular DOX 
fluorescence was observed in both nucleus and cytoplasm. 
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Figure 10  CLSM images of the intracellular distributions of the DOX-loaded TNPs and free 
DOX in MCF-7/ADR cells 
CLSM images of the intracellular distributions of the DOX-loaded TNPs and free DOX with the 
same DOX concentration (10µM) in MCF-7/ADR cells for different time incubation (1 h and 3 h). 
The cells were stained with Lysotracker® green DND-26 (green) and Hoechst 33342 (blue). The 
pink color shows the localization of DOX (red) in nucleus (blue), and the yellow color indicates the 
localization of DOX (red) in endosomes/lysosomes (green). The scale bars represent 10 μm. 
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The TNPs were not possible to enter the nucleus due to size limitations for entry 
via the nuclear pore complex.[89] The results indicated that the TNPs could 
enhance the cellular uptake of DOX, and then affected its nuclear localization in 
both sensitive and resistant tumor cells. These observations demonstrated that 
the TNPs might be an effective nanocarrier to efficiently transport DOX into both 
sensitive and resistant tumor cells.  
TNPs enhance in vitro cytotoxicity of DOX against sensitive and resistant 
tumor cells 
 
Due to the enhanced intracellular DOX uptake by the TNPs in sensitive and 
resistant cell lines, we hypothesized that the TNPs could confer higher 
cytotoxicity against sensitive or even resistant tumor cells by enhancing 
intracellular delivery of drugs. To verify the hypothesis, we investigated the in 
vitro cytotoxic activity of the DOX-loaded TNPs against the sensitive cell lines 
and the resistant cell line for cancer therapy. First, it was determined that the 
TNPs had no cytotoxicity from 1.28 ng/ml to 100 µg/ml in the three cell lines after 
48h treatment (Figure 11A). Different tumor cells were then treated with the 
DOX-loaded TNPs and free DOX at a series of DOX concentrations. Figure 11B-
D shows the dose-dependent cell viability with the DOX-loaded TNPs and free 
DOX. The IC50 values for DOX-loaded TNPs and free DOX are listed in Table 2, 
indicating the enhancement of cytotoxic effect on DOX-loaded TNPs.  
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Figure 11  In vitro cytotoxicity of the TNPs and DOX-loaded TNPs 
In vitro cytotoxicity of the TNPs (A) and the DOX-loaded TNPs in human lung cancer A549 (B), 
human breast cancer MCF-7 (C), and its drug resistant cell line MCF-7/ADR (D). All tumor cells 
were treated with the blank TNPs at the concentration of 1.28 ng/ml to100 µg/ml for cytotoxic test 
of the TNPs themselves. For the DOX-loaded TNPs and free DOX, the DOX dosage was from 
0.1 nM to 10 µM (for A549 cells), from 0.3 nM to 20 µM (for MCF-7 cells), and from 0.5 nM to 40 
µM (for MCF-7/ADR cells). The cells were treated with different samples for 48 h. Data are 
presented as the mean ± SD from three independent experiments. 
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Table 2 IC50 values (µM) of free DOX and the DOX-loaded TNPs in lung 
cancer A549 cells, human breast cancer MCF-7 and its drug-resistant cell 
line MCF-7/ADR after 48 h incubation. 
IC50(µM) A549 MCF-7 MCF-7/ADR 
DOX 0.30±0.05  0.46±0.09  69.69±21.67  
DOX-loaded 
TNPs 
0.026±0.005* 0.036±0.012* 15.16±7.05*  
Note: IC50 was determined by using ―Dose Resp‖ function of OriginPro 8.0; *P<0.05 as compared 
with free DOX. 
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Treatment of A549 cells with the DOX-loaded TNPs (from 0.64 nM to 10 µM) had 
significant higher cytotoxicity than the treatment with free DOX (p<0.05), with a 
half-maximal value of ~0.3µM (for free DOX) compared to ~0.026µM (for the 
DOX-loaded TNPs). Similarly, the IC50 value of the DOX-loaded TNPs (~0.036 
µM) against MCF-7 cells was significantly lower than that of free DOX (~0.46 µM) 
(p<0.05), indicating much higher cytotoxicity of the DOX-loaded TNPs. In both 
cell lines, the IC50 value was ~12 times lower when associating of DOX with the 
TNPs (Table 2). More interestingly, in the case of resistant MCF-7/ADR cells, the 
IC50 value of the DOX-loaded TNPs was about 15.16 µM, which was 4.6 times 
lower than that of free DOX (69.69 µM) (p<0.05) (Table 2). The data indicated 
that the enhanced DOX uptake exerted by the TNPs could effectively increase 
the cytotoxicity against both sensitive and resistant tumor cells. The cytotoxicity 
data combined with the increased cellular uptake substantiate the use of the 
TNPs as a nanocarrier for the delivery of cancer therapeutics, especially for 
multidrug resistant tumors. 
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Further purification of the TNPs 
 
It is well-known that the bioactivity of nature-based nanoparticles depends on 
their chemical characteristics. Thus, the verification of the components and their 
chemical structures in the TNPs is very important for the future biomedical 
applications. In this thesis, the TNPs were simply purified by using weak anion 
exchanger (WAX) and size exclusion chromatography (SEC). The TNPs were 
subjected to ion exchange chromatography on a 10×70 mm column of DEAE-
cellulose. Different fractions were prepared in a stepwise elution with a series 
concentration of NaCl (0.1-1 M) solution, and with collection of 1 ml for each tube. 
The nanoparticles content in each fraction were determined by anthrone-
sulphuric acid method [54]. The elution pattern plotted by the anthrone-sulfuric 
acid method suggested these fractions contained abundant polysaccharides. The 
fractions eluted with 0.2 M NaCl gradient, and then chromotographed on the 
Sephadex G75 in DI water, were designated TNP-D1 (Figure 12 A). Similarly, 
the fractions eluted with 0.3 M NaCl gradient, and then chromotographed on the 
Sephadex G75 in DI water, were designated TNP-D2 (Figure 12 B). These 
results suggested that TNP-D2 had the stronger negative charge owing to the 
elute solvent was the higher concentration of NaCl (0.3 M), while TNP-D1 had 
the weaker negative charge owing to the elute solvent at the lower concentration 
of NaCl (0.2 M). 
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Figure 12 Elution profile of the isolated TNP-D on a DEAE-cellulose column (10×70mm).  
TNP-D1 was eluted with 0.2M NaCl and B) TNP-D2 was eluted with 0.3M NaCl. 
 
.   
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The purified fractions were further characterized by AFM, DLS and ELS. As 
shown in Figure 13, all the purified fractions contained a large amount of 
spherical nanoparticles had similar particle size of 50-100 nm in diameters. The 
surface charge potential of the purified TNPs was analyzed using ELS, and the 
zeta potential of TNP-D2 was found to be -44.9 at pH 7.0, which was lower than 
those of TNP-D1 (-32 mV) (Table 3). These results further supported the elution 
profiles through the WAX column that the lower surface charges of TNP-D1 were 
easily eluted at lower concentration of NaCl solution (0.2M). In addition to the 
morphology, sizes and zeta potentials, it was found that neutral polysaccharides 
were considered to be the main components for TNP-D1, TNP-D2 fractions, 
which is similar to the TNPs. The presence of neutral polysaccharides was 
shown in TNPs, TNP-D1 and TNP-D2 by PAS staining after SDS-PAGE analysis 
(Figure 13). The quantitative data of polysaccharides and proteins in all samples 
were listed in Table 3. To further identify the functional groups in different TNP 
fractions, FTIR analysis was employed. As shown in Figure 14, the IR spectra of 
all samples exhibited the obvious characteristic absorption at 3600-3200 cm-1, 
3000-2800 cm-1, 1400-1200 cm-1, 1200-1000 cm-1 corresponding to the 
existence of polysaccharides [90]. The absorption peaks at around 1650 and 
1250 cm-1 indicated the existence of ring sugar [91]. The strong peak at around 
3400 cm-1 was assigned to –OH stretching. The peaks at 1740 cm-1 and 1632 
cm-1 were attributed to C-O stretching vibration of carbonylic group and N-H 
vibration or C=O asymmetric vibration of carboxyl group, which were also the 
characteristics of polysaccharides [90].   
  49 
 
Figure 13 Characterization of purified TNPs 
AFM images of purified TNPs: TNP-D1 (A), TNP-D2 (B). The size distribution of the purified TNPs: 
TNP-D1 (C), TNP-D2 (D) at pH=7.0 in suspension measured by DLS. (E) Analysis by SDS-PAGE 
of crude TNP samples: TNPs and purified TNP samples: TNP-D1 and TNP-D2. Samples were 
prepared in DI water and separated on 10% SDS-PAGE. Gel stained with PAS showed the 
neutral polysaccharides in all samples. 
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Table 3 Characterization of the purified TNPs via AEX and SEC procedures 
Samples  TNP  TNP-D1  TNP-D2  
Size(nm)  306.1  330.0  263.7  
PDI  0.301  0.206  0.293  
Zeta Potential (mV)  -32.5±2.4  -32±1.2  -44.9±0.7  
Polysaccharide (mg/ml)  1.20±0.015  0.53±0.11  0.45±0.006  
Protein (mg/ml)  0.67±0.005  0.05±0.004  0.03±0.001  
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Figure 14 FTIR spectra of TNPs (Black), TNP-D1 (Red) and TNP-D2 (Blue) in the range of 
4000-800 cm-1. 
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Conclusions 
In this work, an infusion-dialysis based procedure for isolating organic 
nanoparticles from green tea was developed. Using this method, the TNPs 
isolated were spherical with diameters of 100-300 nm and a zeta potential of -26 
mV at pH 7.0. Chemical analyses revealed that there were two macromolecules 
(polysaccharide and protein) and no small molecules (EGCG, caffeine and 
theobromine) were identified in the TNPs. It was determined that the TNPs had 
an immunostimulatory effect by inducing the secretion of various cytokines (IL-6, 
TNF-α, G-CSF) and chemokines (RANTES, IP-10, MDC) from RAW264.7 mouse 
macrophages. Further analysis showed that DOX could be effectively loaded 
onto the TNPs via electrostatic and hydrophobic interactions. More importantly, 
compared to free DOX, greater DOX uptake was observed for the DOX-loaded 
TNPs in sensitive tumor cells (A549 cells and MCF-7) and drug resistant tumor 
cells (MCF-7/ADR), all resulting in the enhanced cytotoxicity. Although the 
underlying mechanism of how the TNPs facilitate the DOX uptake in tumor cells 
and eventually lead to higher cytotoxic activity is still unknown; however, 
considering the immunostimulatory activity of the TNPs, this work provides a 
potential basis for utilizing the multifunctional nanoparticles from tea to improve 
antitumor efficacy in the cancer immunochemotherapy.  
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CHAPTER III 
NATURALLY OCCURRING NANOPARTICLES FROM 
ARTHROBOTRYS OLIGOSPORA AS A MULTIFUNCTIONAL 
DRUG CARRIER FOR TUMOR IMMUNOCHEMOTHERAPY 
 
  
  54 
Introduction 
Cancer is a leading cause of death worldwide, accounting for 7.6 million deaths 
(around 13% of all deaths) in 2008, and the deaths are expected to continue 
rising, with an estimated 13.1 million in 2030 [92]. Chemotherapy is generally 
regarded as the first line approach for the treatment of malignant cancer in the 
past decades [93, 94]. However, conventional chemotherapy remains a daunting 
challenge to the successful treatment of metastatic tumors and becomes 
ineffective in many patients after first few treatments [95]. This might be due to 
the tumor heterogeneity, plasticity, and ineffective drug delivery to tumor tissues 
and cells, which enable a subgroup of cancer cells to mutate and evade the 
chemotherapy [96-98]. Simply increasing drug dose does not guarantee 
elimination of this subset of tumor cells, but would eventually lead to systemic 
toxicity in normal tissues and high frequency multi-drug resistance in tumor cells 
[95, 99].  
To evade the emergence of the systemic toxicity and therapy resistance, it is 
critical to design a treatment modality with multiple mechanisms of cell killing in 
tumors. One such therapy is the combined immuno-chemo-therapeutic regimen, 
which has demonstrated great potential in maximizing the clinical outcomes of 
cancer patient due to synergistic antitumor effects between chemotherapy and 
immunotherapy [100]. Different clinical trials incorporating cancer vaccines, 
immune checkpoint blockade, or adoptive cellular therapy have typically tested 
the immunotherapies integrated with standard-dose chemotherapy [101]. Current 
clinical data suggest that combined immunochemotherapy regimens are not only 
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drug dependent but also dependent on drug dose, timing and schedule in related 
to immune-based intervention [100, 101]. Because of the aforementioned 
strategy conditionally dependent synergism between chemotherapy and 
immunotherapy, it is expected that developing rational carriers that could 
incorporate and simultaneously deliver both immune-stimulating and cytotoxic 
chemotherapeutic agents [102] may be facilitate the precise temporal and spatial 
delivery of different therapeutics. From this perspective, a few combination 
therapies using engineered nanoparticle-based delivery systems, including 
nanoparticles [102, 103], liposomes [104-106] and macromolecular conjugates 
[98], etc, in conjunction with different chemical drugs and immune-stimulants, 
have been reported for chemoimmunotherapy in various cancers, providing 
promising preclinical outcomes[107]. However, among these nanoparticle-
enhanced combinatorial immunochemotherapies, few engineered biomaterials 
themselves have been used as immunostimulants or adjuvants. They are 
generally inert biomaterials, simply conjugated or encapsulated with an 
immunostimulatory agent and a chemo-drug for the use of the combined 
antitumor therapy. Due to the complex pathogenesis of malignancy, which 
juxtaposes intrinsic aberrations in tumor cells with profound effects on the host 
innate and acquired immune system, it demands a multi-functional therapeutic 
strategy that targets tumor cells and improves or reestablishes antitumor immune 
responses [108]. Thus, future rational immunochemotherapies call for novel 
therapeutic biomaterials with multi-functional modes of action, in conjunction with 
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conventional chemo-drugs, to establish the utility and feasibility of 
immunochemotherapy [108]. 
 
Naturally occurring nanoparticle is an alternative source for production of 
biopolymer-based nanoparticles with diverse properties and biofunctions through 
different biological systems. The use of naturally occurring organic nanoparticles 
and their biomimetic/bioinspired nanomaterials in biomedical and industry fields 
have recently drawn significant interest from scientific communities. In previous 
study, our group first discovered that the adventitious roots of English ivy 
secreted organic nanoparticles and demonstrated that they were an attractive 
candidate for sunscreen fillers [23]. Similar organic nanostructures have been 
discovered in the secretions of a variety of marine species, including polychaetes, 
mussels, barnacles, and sea stars [109-113] and their potential applications in 
diverse industry fields were also explored and discussed [25]. It is anticipated 
that the study on naturally occurring nanoparticles will not only help us to 
understand the roles of nanoparticles in biological systems, but also provide 
insight into the development of these nanomaterials for novel treatment of 
diseases. As a natural counterpart of engineered nanoparticles, naturally 
occurring organic nanoparticles, with multi-pronged modes of action in the 
context of cancer therapy, may be approached in the same way as other 
engineered inert nanoparticles that have been used for the aforementioned 
combined immunochemotherapy, producing improved immune responses. In 
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2012, our group has first revealed that the secreted nanoparticles from a 
carnivorous fungus, Arthrobotrys oligospora, had promising properties as an 
immunostimulatory and antitumor agent for cancer treatment [114]. A. oligospora 
is a representative flesh eater in the fungal kingdom, and it can develop into the 
specialized 3D adhesive traps for capturing, penetrating and digesting free-living 
nematodes in diverse environments [115]. The natural-based nanoparticles from 
A. oligospora, designated as fungal nanoparticles (FNPs) in this study, had mild 
cytotoxic activity in tumor cells, induced the secretion of tumor necrotic factor 
(TNF-α) from macrophage, and could be simultaneously used as a drug carries 
for chemical drug delivery into the tumor cells [114]. Therefore, the novel 
therapeutic bionanomaterial from this carnivorous fungus would be a new 
multifunctional modality for optimal cancer treatment by simultaneously 
modulating immune system, direct killing antitumor cells and delivery chemo-drug 
into tumor cells and tissues. 
 
The purpose of this study was to further evaluate the immunostimulatory activity, 
dissect the mechanism of the cytotoxicity, and explore the potential in cancer 
immunochemotherapy using the FNPs as a multifunctional nanocarrier in vitro. 
We have established a cost-effective and robust platform to produce and collect 
the FNPs from the sitting drop culture system established in our lab. The FNPs 
collected by a washing-dialysis procedure in our previous study showed a size of 
200-300 nm in diameters measured by SEM/AFM, and even 300-400 nm in 
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aqueous solution measured by DLS analysis [114]. From the perspective of mere 
passive targeting tumor in vivo, the upper bound size for nanoparticles 
participating in the enhanced permeability and retention (EPR) effect is believed 
to be approximately 400 nm[116], and an effective drug carrier for in vivo cancer 
treatment should have a diameter less than 200nm considering the multiple 
factors in vivo, such as limited fenestration size of the leaky vasculature in 
tumors and rapid systemic clearance [99]. Thus, in this study, we first established 
a new approach for purification of the crude FNPs collected from the sitting drop 
culture system in order to obtain the purified FNPs with proper size ranges, 
followed by characterization of critical physical-chemical properties of the purified 
FNPs. The purified FNPs used as a novel multifunctional nanocarrier for cancer 
immunochemotherapy in vitro was investigated, including immunostimulation, the 
mechanism of the cytotoxicity, synergistic cytotoxicity, drug delivery into tumor 
cells and combined immunochemotherapeutic effect. Here we report a novel 
immunochemotherapy approach based on the multifunctional fungal 
nanoparticles, which may open a new avenue for combined cancer 
immunochemotherapy in the future. 
  
  59 
Materials and Methods 
Chemicals, fungus and cell lines 
 
Arthrobotrys oligospora (ATCC 24927), A549 human non-small-cell lung cancer 
cells (CCL-185) and RAW 264.7 murine macrophages (TIB-71) were obtained 
from the American Type Culture Collection (Manassas, VA). B16BL6 murine 
melanoma cells, MCF-7 human breast tumor cell line and its resistant cell line 
MCF-7/ADR were obtained from the National Cancer Institute-Central Repository 
(Frederick, MD). Splenocytes, derived from C57BL/6 mice, were purchased from 
the Allcells Company (Emeryville, CA). HEPES, 1, 9-dimethyl-methylene blue 
(DMMB), chondroitin sulfate (CS), Sephadex G75, DEAE-cellulose and 
phosphate buffered saline (PBS) were purchased from Sigma-Aldrich (St. Louis, 
MO). Doxorubicin hydrochloride (DOX) was purchased from Abcam (Combridge, 
MA). LysoTracker Green DND-26 and Hoechst 33342 were purchased from 
Invitrogen Life Technologies (Grand Island, NY). Fetal bovine serum, DMEM 
medium and RPMI 1640 medium were purchased from Mediatech (Manassas, 
VA). Penicillin (10000 units/ml)-streptomycin (10000 µg/ml) solution was obtained 
from MP biomedicals (Solon, OH). 
Arthrobotrys oligospora culture and purification of FNPs 
 
A. oligospora was cultured in the sitting drop culture system as the previously 
study [114] with minor modifications. Briefly, conidia suspension (about 1000-
2000 conidia in 200 µl) was inoculated into the media droplet and incubated at 
25˚C for 7 days. The isolation procedures were shown in Figure 15A.  
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Figure 15 Schematic of a new isolation method, SEC-WAX-SEC procedure 
For the FNP purification (A), and the elution profiles of the FNPs-containing media collected by 
washing mycelia in the sitting drop culture system using a size exclusion chromatography (SEC, 
Sephadex G75, 15 mm×70 mm) column (B) and a weak anion exchange (WAX, DEAE-cellulose, 
10mm×70mm) column (C). The FNPs isolated from SEC column was designated as FNP0, which 
is a crude nanoparticle sample. After loading FNP0 into the WAX column, two FNP fractions 
eluted from 0.5M NaCl and 1.0M NaCl were designated as the FNP1 and FNP2, respectively. 
The FNPs were qualitatively determined by colorimetrically measuring the absorbance (λ525) of 
glycosaminoglycan (GAG) in the FNPs (M&M Section 2.2).  
  
(A) 
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First, the mycelia developed on the cover slip were washed more than 10 times 
using distilled water. The wash water containing nanoparticles was collected, and 
the samples were then filtered through a 0.2 µm syringe filter (cellulose acetate, 
VWR, Radnor, PA). The FNPs were desalted by a Sephadex G75 column as 
reported previously [56]. The desalted FNPs is designated FNP0, which is a 
crude sample. To purify the FNP0, weak anion-exchange (WAX) chromatography 
on DEAE-cellulose was performed as described previously [117]. The DEAE-
cellulose columns were then eluted in a stepwise fashion with 0.1 M, 0.2 M, 0.3 
M, 0.5 M and 1.0 M NaCl. As our previous study, glycosaminoglycan (GAG) is 
one of the main components in the FNPs [114]. Thus, the colorimetric assay 
(λ525nm) for GAG with 1, 9-dimethyl-methylene blue was used to monitor the 
FNPs in the eluent from the DEAE-cellulose column. The elution profiles of the 
FNPs, reflected from GAG concentration, were plotted versus elution volumes. 
The collected peaks containing FNPs from WAX column were subjected to the 
Sephadex G-75 column for desalting, and the desalted FNPs were concentrated 
to final volume of 150µl using a centrifugal filter tube (Amicon Ultra-15 100K, 
Merck Millipore, Ireland). 
Characterization of FNPs 
 
To characterize morphology and particle size of the FNPs, the samples were 
analyzed using AFM (MFP-3D, Asylum Research, Santa Barbara, CA). Briefly, 
10µl of the particle solution was air-dried on a glass cover slip, and analyzed in 
AC mode based on the software Igor Pro from Wavemetrics and an ACTA Probe 
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from AppNano (Santa Clara, CA) at room temperature. The nanoparticle samples 
were further analyzed by dynamic light scattering (DLS) and electrophoretic light 
scattering (ELS), using a Zetasizer Nano (Malvern Instruments Ltd, 
Worcestershine, UK), to determine the size distribution and zeta potential of the 
samples in solution. To qualitatively determine the chemical components in the 
nanoparticles, SDS-PAGE was used for staining the GAG and neutral 
polysaccharides in the nanoparticles using Alsian blue and PAS reagents 
(Thermo Scientific, MI), respectively. To quantitatively determine the chemical 
components in the nanoparticle samples, the total amounts of polysaccharides 
were measured using the anthrone-sulfuric acid assay [54]. The amount of GAG 
in each sample was determined by a Proteoglycan Detection Kit (1, 9-
dimethylmethylene blue, Astarte Biologics, Redmond, WA) [114], and the uronic 
acid in the nanoparticles were determine using carbozole assay [118]. Meanwhile, 
the concentration of protein in the samples was quantitatively determined by the 
BCA protein assay (Pierce, Rockford, IL) following the manufacturer’s 
instructions. In addition, the endotoxin concentration in the nanoparticle samples 
was measured by using the ToxinSensor Chromogenic LAL Endotoxin Assay Kit 
(GenScript, Piscataway, NJ) following the manufacturer’s instructions. 
Immunostimulatory activity 
 
The mouse macrophage RAW 264.7 cells and splenocytes derived from 
C57BL/6 mice were cultured in DMEM and RPMI 1640 culture media, 
respectively. Both media were supplemented with 10% FBS and 1% penicillin- 
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streptomycin at 37°C in 5% CO2. The cells were plated in 12-well plates at a 
density of 5×106 cells/ml, treated with the FNPs at the GAG concentration of 
5µg/ml. After a 24-h incubation, the supernatants were collected for ELISArray 
analysis. Mouse common cytokines and chemokines multi-analyte ELISArray kits 
(SABiosciences Corporation, Frederick, MD) were used to determine 12 
cytokines (IL-1A, IL-1B, IL-2, IL-4, IL-6, IL-10, IL-12, IL-17A, IFN-γ, TNF-α, G-
CSF, and GM-CSF) and 12 chemokines (RANTES, MCP-1, MIP-1a, MIP-1b, 
SDF-1, IP-10, MIG, Eotaxin, TARC, MDC, KC, and 6Ckine) in the supernatants 
following the manufacturer’s instructions. The concentration of nitric oxide (NO) 
in the supernatants of both cells treated with the FNP samples were also 
determined using Griess assay, as described elsewhere [119].  
MTT assay 
 
The cytotoxicity of the purified FNP samples and the DOX-FNP complexes 
against four cancer cell lines (A549, B16BL6, MCF-7 and MCF-7/ADR cells) was 
evaluated by MTT assay as early described [56], and the biocompatibility of the 
purified FNP samples toward mouse fibroblast NIH3T3 cell was also measured 
with MTT assay[120]. Briefly, 8000-10000 cells were plated in 96-well plates in 
100 µl culture media per well and incubated at 37 °C in 5% CO2 for 24 h to allow 
the cells to attach. Specifically, DMEM were used for A549 and B16BL6 cells, 
RPMI 1640 for MCF-7 and MCF-7/ADR cells and DMEM-α for MIH3T3 cells. The 
media were supplemented with 10% fetal bovine serum (for tumor cells) or calf 
serum (only for NIH3T3), and 1.0 % penicillin-streptomycin. The cells were then 
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treated with different concentrations of the FNPs or the DOX-FNP complexes. 
After a 48-h treatment, 10 μl of MTT solution (5 mg/ml in PBS, pH 7.4) was then 
added to each well and the plates were incubated for another 4 h. The cell 
culture media were removed and replaced with 100 µl DMSO. The absorbance 
was measured by a microplate reader (Bio-Tek µQuant) at 570 nm. For the DOX-
FNP complexes, the average IC50 value (the dose having 50% cell inhibition) was 
determined by cell survival plots using the ―DoseResp‖ function in OriginPro 8.0.  
Apoptotic assay 
 
The apoptosis study was determined by evaluating DNA ladder formation [121]. 
Briefly, A549 cells and B16BL6 cells were treated with the FNP samples at the 
GAG concentration of 10µg/ml, and then incubated at 37 °C in 5% CO2 for 48h. 
Apoptotic cells were identified by TdT-mediated dUTP nick and labeling (TUNEL) 
assay using APO-BrdUTM TUNEL Assay Kit (Invitrogen, Eugene, OR) according 
to the manufacturer’s instructions. The cells were then analyzed using flow 
cytometry (Epics XL Analyzer, Beckman Coulter Inc., Brea, CA) by collecting 
20000 events for each sample and measuring the cell associated fluorescence.  
Cell cycle analysis 
 
To determine cell cycle distribution, A459 and B16BL6 cells were passed into 24-
well plates and treated with the FNP samples at the GAG concentration of 
10µg/ml, and then incubated at 37°C in 5% CO2 for 24h. The cells were then 
trypsinized, washed with PBS, and fixed in 75% ethanol at 4°C for 2 h. The fixed 
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cells were stained with propidium iodide/RNase A staining buffer (Invitrogen, 
Eugene, OR) at 37˚C for 30 min in the dark. The cell cycle analysis was 
conducted using flow cytometry (Epics XL Analyzer, Beckman Coulter Inc., Brea, 
CA) by collecting 20000 events for each sample and measuring the cell 
associated fluorescence. 
Formation of DOX-FNP complexes 
 
To prepare the complexes between DOX and the FNPs, 60µl of DOX (3mM) was 
added into 110µl of the FNP1 (~143 µg/ml GAG) or 160µl of the FNP2 
(~95µg/ml) in 20mM HEPES buffer at pH 7.0, and then incubated at room 
temperature overnight. The precipitates between DOX and the FNPs were then 
centrifuged at 10,000 rpm for 10 min. The precipitates were dispersed in 500µl 
PBS buffer, and then sonicated for 10min in a bath sonicator (Aquasonic 7500, 
VWR). The amount of DOX in the dispersed precipitates was quantified by 
measuring UV absorbance at 480nm and the entrapment ratios of DOX in the 
complexes were calculated as previously reported [56]. To determine the stability 
of DOX in the complexes in the PBS buffer, the dispersed complexes were 
applied to Sephadex G75 column. The first peak, standing for the stable 
complexes, and the second peak, standing for free DOX, was collected for 
quantification. The morphology, particle size and zeta potential of the DOX-FNP 
complexes were characterized using AFM, DLS and ELS analysis, as above 
described. 
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In vitro release study 
 
DOX release from the DOX-FNP complexes was studied at different pH values. 
150µl of the DOX-FNP1 complexes (168µM for DOX), 200µl of DOX-FNP2 
complexes (~126µM for DOX), or 84µl of free DOX (300µM) were placed in a 
dialysis tube (MWCO 300 K, Spectra/por membrane tubing, Spectrum Labs, CA), 
and then immersed in tubes containing 6 ml of release buffers at different pH 
values (1×PBS, pH 7.4; 0.1 M acetic acid buffer, pH 5.5). All tubes were 
incubated at 37˚C under mild agitation. The dialysate sample (0.5 ml) was 
collected at different time points and replenished immediately with the same 
volume of the fresh medium. The concentration of DOX in the dialysate was 
analyzed fluorometrically at λex480 nm and λem590 nm, and the cumulative 
release profiles were plotted verse release times. 
Cellular uptake and confocal microscopic study 
 
The quantification of intracellular DOX uptake in cancer cells was evaluated by 
flow cytometry. A549 and B16BL6 cells were cultured in 6-well plates at densities 
of 1×106 cells/ml, and incubated at 37°C in 5% CO2. The DOX-FNP complexes 
at the DOX concentration of 10µM were added into each well, and free DOX was 
used as a control. After a 4-h incubation, the media were aspirated. The cell 
monolayer was rinsed with PBS for three times, and then trypsinized. Flow 
cytometry analysis was carried out on an Epics XL Analyzer (Beckman Coulter 
Inc., Brea, CA) by collecting 20000 events for each sample.  
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Confocal laser scanning microscopy (FluoView FV1000 Confocal Microscope, 
Olympus, Japan) was used to investigate intracellular DOX distribution in tumor 
cells treated with the DOX-FNP complexes. Briefly, the cells were seeded on 
cover slips with a density of 106 cells/ml in 6-well plates and cultured at 37°C in 
5% CO2 for 24 h. The cells were then treated with the DOX-FNP complexes at 
the DOX concentration of 10 µM for 4h. Free DOX was used as a control. To 
observe the intracellular distribution, endolysosome- and nuclear-specific 
markers, LysoTracker® green (100 nm) and Hoechst 33342 (4µM), were 
incubated with the cells for 30 min prior to the confocal imaging. After that, the 
cover slip was washed with PBS three times, set on a microscope slide, and then 
examined by confocal microscopy.  
To observe the internalization of the FNPs themselves, the FNPs were first 
labeled with FITC. For such a purpose, 3.5mg/ml of FITC in DMSO was diluted to 
0.7mg/ml with 100 mM carbonate buffer (pH 9.3), and then 150μl of the FNP1 
(138.56μg/ml) and FNP2 (56.83μg/ml) were added into 400μl of the above 
carbonate buffer. After a 24-h incubation at the room temperature, resulting 
solution was dialysized (MWCO 300 K, Spectra/por membrane tubing, Spectrum 
Labs, CA) against PBS buffer for three days. After that, the cells were treated 
with the FITC-labeled FNPs at the FITC concentration of 2ng/ml, and the 
internalization of the FNPs was then imaged with confocal microscopy as above 
detailed. 
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Co-culture system for testing immunochemotherapeutic activity 
 
A co-culture system using B16BL6 tumor cells and the splenocytes derived from 
C57BL/6 mice was used to evaluate the immunotherapeutic effect of the DOX-
FNP complexes in vitro [98, 103]. Briefly, 2×105 tumor cells, labeled with 5 μM 
CFSE, were co-cultured with 5 x106 splenocytes, and then the co-cultures were 
treated with free DOX and both DOX-FNP complexes at the DOX concentration 
of 1µM. After a 24-h incubation, the death of tumor cells was determined by the 
PI uptake method using flow cytometer after gating on the CFSE labeled cancer 
cells.  
Statistical analysis 
 
All the values were presented as mean ± standard deviation (S.D.) of at least 
three independent measurements. Statistical significance was tested by one-way 
ANOVA followed by a Student's t test for multiple comparison tests. A p value of 
<0.05 was considered statistically significant. 
 
 
 
  
  69 
Results and Discussion 
Purification and characterization of FNPs  
The sitting drop culture system for the fungus A. oligospora has been established 
in our lab, from which the secreted FNPs was isolated and characterized [114]. 
Using a dialysis procedure, these crude isolates of the FNPs demonstrated a 
spheroidal shape with diameter of 100-500 nm [114]. In this study, we 
established a new purification procedure using a combination of size exclusion 
chromatography (SEC) and weak anion exchanger (WAX) to purify the FNPs. As 
shown in Figure 15A, after inoculation of at least 1000 conidia per cover slip on 
which about 500µl of media drop was added, the fungal mycelia were grown for 7 
days and the mycelia thrived on the cover slip were washed using distilled water. 
The collected wash media were then filtered to remove any debris, and then 
applied to Sephadex G75 column. Through the SEC column, the first peak, 
designated as FNP0, was collected (Figure 15B), and characterized using AFM. 
As shown in Figure 16A-B, spheroidal nanoparticles with 100-300nm in diameter 
were observed. The nanoparticle FNP0 was further analyzed with DSL and ESL, 
showing average size of ~300nm (Figure 16C) and negative zeta potential of 
~30 mV (Table 4). These crude isolates of FNPs were further applied to DEAE-
cellulose column, leading to production of two FNP fractions that were eluted 
respectively using 0.5M NaCl and 1.0M NaCl (Figure 15C). Both FNP fractions, 
designated respectively as FNP1 and FNP2, were further characterized for their 
morphology, hydrodynamic size and zeta potential using AFM, DLS and ELS.  
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Figure 16 AFM images (A-B, D-E and G-H) and size distribution (C, F and I) of the FNPs 
prepared with the SEC-WAX-SEC procedure. 
 (A-C) The nanoparticle FNP0, prepared with only SEC procedure (Sephadex G75 column); (D-F) 
The nanoparticle FNP1, prepared with the SEC-WAX-SEC procedure and eluted with 0.5M NaCl; 
(G-H) The nanoparticle FNP2, prepared with the SEC-WAX-SEC procedure and eluted with 1.0M 
NaCl.  
  
(B) 
(E) 
(G) (H) 
(F) 
(I) 
(A) (C) 
(D) 
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Table 4 Physicochemical characterization of the FNPs prepared with the 
SEC-WAX-SEC procedure 
 
 
 
 
 
 
 
 
Note: * The concentrations of protein, glycosaminoglycan (GAG), uronic acid and total sugar in 
the FNPs were determined after they were concentrated to 150 µl using a spin filter (M&M 
Section 2.2&2.3). Therefore, the unit here is designated as µg/ml nanoparticle solution instead of 
µg/mg freeze-dried nanoparticles. All concentrations were based on the following preparation 
methods: the FNP0 was prepared using one batch of fungal culture (40 small disks), and the 
purified FNP1 and FNP2 were prepared using three batches of fungal culture (120 small disks). 
 
  
 
Size  
(nm) 
Zeta 
potential 
(mV) 
Protein 
(µg/ml*) 
GAG 
(µg/ml*) 
Uronic acid 
(µg/ml*) 
Total Sugar 
(µg/ml*) 
FNP0 294.2 ± 152.3 -30.7 ± 9.1 
661.1 
±10.7 
187.6 
±10.7 
162.6±23.1 410.1±6.4 
FNP1 147.5 ± 78.4 -26.9 ± 6.9 86.8 ±6.3 
296.5 
±38.1 
153.9±10.8 506.2±25.2 
FNP2 148.5 ± 67.4 -32.1 ± 7.6 3.7 ±0.7 98.7 ±7.4 40.4±7.7 162.7±8.5 
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As shown in Figure 16 D-F, the first peak (FNP1), eluted from 0.5M NaCl, were 
spheroidal nanoparticles with ~150nm in hydrodynamic diameter. The second 
peak, FNP2, had similar hydrodynamic size with spheroidal morphology (Figure 
16 G-I). However, as shown in Table 1, the FNP1 had zeta potential of ~ -27 mV, 
which is lower than that of FNP2 (~ -32mV). The difference in zeta potentials for 
both FNP fractions is consistent with their elution profiles through the WAX 
column. Due to relatively lower surface charge of the FNP1 fraction, it was eluted 
more easily at low concentration of NaCl than FNP2 fraction [117] (Figure 15 C). 
Therefore, at low salt concentration, i.e. 0.5M NaCl, the FNP1 was first eluted, 
and then the FNP2 was selectively eluted at higher concentration, i.e. 1.0M NaCl.  
Apart from the differences in morphology, sizes and zeta potentials, FNP1 and 
FNP2 had chemical components as similar as the crude FNP0. As shown in 
Figure 17 A-B, glycosaminoglycan (GAG) and neutral polysaccharides were 
demonstrated to be the major components for both FNP1 and FNP2 fractions, 
which is similar to the crude FNP0 sample. The quantitative data for GAG, uronic 
acid and total sugars in the three FNPs are listed in Table 4. For the protein 
component in the three FNP samples, the ratio of protein to total sugar in the 
FNP0 was much higher than those in the TNP1 and TNP2 (Table 4), indicating 
most proteins in the crude FNP0 were free and unbound proteins. These proteins 
were not bound to FNPs, leading to complete washing away through the 
purification procedure with lower salt concentration (< 0.5M NaCl). Therefore, 
compared to the amount of total sugar, the purified FNP1 and FNP2 only had 
lower ratios of proteins to total sugars in the nanoparticles. 
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Figure 17 SDS-PAGE analyses of polysaccharides in the FNPs by using Alcian blue 
staining (A) and PAS staining (B).  
Alcian blue were used for glycosaminoglycan (GAG) staining and PAS for neutral polysaccharide 
staining. 
  
(A) (B) 
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Due to most GAGs covalently attaching to core proteins to form proteoglycan 
[122], we presume that some proteins probably were bound to the GAGs in the 
nanoparticles. On the other hand, two protein bands were observed in the FNP 
sample prepared using dialysis method in our previous report [114] and the 
protein bands with similar MW were also observed in the FNP0 samples in this 
study. For the purified FNP1 and FNP2, both similar protein bands with relatively 
weaker intensities were also appeared in the SDS-PAGE analysis (Data not 
shown). No matter how the proteins are chemically bound to or physically 
associated with the FNPs, the polysaccharides, including acidic GAG and neutral 
polysaccharides, are main chemical components in the purified FNPs.  
 
FNPs stimulate secretion of multiple proinflammatory cytokines and 
chemokines from macrophage and splenocytes 
In our previous study, it has been demonstrated that the FNPs prepared using a 
dialysis approach induced the secretion of TNF-α from a macrophage cell line 
RAW264.7 in a dose-dependent manner [114], indicating the potential of 
antitumor immunity using the FNPs. In this work, after obtaining the purified 
FNPs, FNP1 and FNP2, macrophage stimulatory activity was first studied using 
the cultured mouse macrophage RAW 264.7 as a cell model. As shown in Figure 
18A, after a 24-h incubation of the FNP-treated macrophage RAW264.7 at the 
GAG concentration of 5µg/ml, ELISArray demonstrated significantly elevated 
levels of IL6, TNF-α, and G-CSF from the macrophage treated by the three FNP 
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samples, FNP0, FNP1 and FNP2, as compared to the untreated cells. Of the 
panel of 12 cytokines assayed, except for above three cytokines, low but 
statistically significant increases in IL1α and IL17A were also detected for the 
FNP1 and FNP2 in the supernatant of the treated macrophage, respectively. As 
is well known, TNF-α is a Th1-biased cytokine as a potential anticancer agent for 
many years [123], playing a key role in apoptosis, cell survival, inflammation and 
immunity [69]. It has been demonstrated that TNF-α was critical for antitumor T 
cell immunity in mice [124] and could act synergistically with other drugs at the 
molecular level to trigger the apoptosis and dissociation of tumor vascular 
endothelial cells in cancer treatment [70, 71]. As a Th2-biased cytokine, IL-6 
plays key roles in T-cell-mediated immune responses, acting as a cofactor for T-
cell proliferation [73], and as a growth inhibiting factor, the antitumor effects of IL-
6 on multiple murine tumor in vivo has been reported [125-127]. G-CSF can 
enhance the differentiation of stem cells in bone marrow, facilitate the 
mobilization of hematopoietic precursor cells into the bloodstream [75],and 
accelerate recovery from chemotherapy-induced myelosuppression [128]. The 
synergistic antitumor effect of TNF-α and G-CSF has been established and 
antitumor effect of TNF was enhanced by combination with G-CSF in multiple 
tumors in vivo [129]. As such, we presume that significant higher amount of TNF-
α, IL-6 and G-CSF secreted from the treated macrophages will be benefit for 
adjuvant anticancer therapy using the FNPs. FNP0, FNP1 and FNP2, as 
compared to the untreated cells. Of the panel of 12 cytokines assayed, except for 
above three cytokines, low but statistically significant increases in IL1α and IL17A 
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were also detected for the FNP1 and FNP2 in the supernatant of the treated 
macrophage, respectively. As is well known, TNF-α is a Th1-biased cytokine as a 
potential anticancer agent for many years [123], playing a key role in apoptosis, 
cell survival, inflammation and immunity [69]. It has been demonstrated that TNF-
α was critical for antitumor T cell immunity in mice [124] and could act 
synergistically with other drugs at the molecular level to trigger the apoptosis and 
dissociation of tumor vascular endothelial cells in cancer treatment [70, 71]. As a 
Th2-biased cytokine, IL-6 plays key roles in T-cell-mediated immune responses, 
acting as a cofactor for T-cell proliferation [73], and as a growth inhibiting factor, 
the antitumor effects of IL-6 on multiple murine tumor in vivo has been reported 
[125-127]. G-CSF can enhance the differentiation of stem cells in bone marrow, 
facilitate the mobilization of hematopoietic precursor cells into the bloodstream 
[75], and accelerate recovery from chemotherapy-induced myelosuppression 
[128]. The synergistic antitumor effect of TNF-α and G-CSF has been established 
and antitumor effect of TNF was enhanced by combination with G-CSF in 
multiple tumors in vivo [129]. As such, we presume that significant higher amount 
of TNF-α, IL-6 and G-CSF secreted from the treated macrophages will be benefit 
for adjuvant anticancer therapy using the FNPs. To confirm this, 
immunostimulation of the FNPs was further evaluated using the primary 
splenocytes isolated from C57BL/6 mice, which have all types of immune cells 
and the cross talk between immunocytes, including macrophage and T cells [98, 
103]. 
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Figure 18  Effects of the FNPs on the secretion of cytokines (A and B), chemokines (C and 
D) and nitric oxide (E and F) from RAW 264.7 macrophage cells (A, C and E) and 
splenocytes (B, D and F).  
The macrophage RAW264.7 cells and splenocytes were treated with the FNPs at the GAG 
concentration of 5µg/ml for 24 h, and then the culture media were collected. A panel of 12 
cytokines and 12 chemokines in the culture media were measured using ELISArry kits, and the 
nitric oxide in the culture media was detected with Griess assay. The results are expressed as 
mean ±SD. *P < 0.05, †P < 0.01, significantly different from the controls.     
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As expected, significantly higher amount of IL6 and TNF-α were detected in the 
culture supernatant of the splenocytes treated with the three FNP samples 
(Figure 18B) in comparison with the untreated control. The other stimulatory 
cytokines, including IL-1α, IL-1β and IL2, were also secreted in a low but 
significantly higher amount from the treated groups with the three FNP samples. 
It has been reported that IL-1 has multiple effects, involving immunomodulation, 
inflammation, wound healing, hematopoiesis, metabolism and the endocrine 
system [130]. IL-1, including IL1α and β, also has a number of properties 
potentially useful in the treatment of cancer, including direct antiproliferative 
activity against certain human tumor cell lines and several murine tumors, the 
activation of effector cells in vitro, and the inhibition of tumor angiogenesis [130]. 
In addition, IL-1 has the capacity to protect and restore the bone marrow from 
radiation or chemotherapy-induced injury [130]. The cytokine IL-2 is known to be 
a T-cell growth factor, inducing clonal expansion of T cells following antigen 
stimulation, and is also important for the differentiation of CD4+ T cells into Th1 
and Th2 effector subsets [73]. IL-2 has been used for the treatment of melanoma 
and renal cell carcinoma [131], and recombinant human IL-2 is a potent cytokine 
and a FDA-approved anticancer drug [132]. As such, we believe that the three 
cytokines, IL-1α, IL-1β and IL-2, with elevated levels in the supernatant of 
splenocytes after the treatment with the FNPs also favor the antitumor immunity 
in the cancer treatment. Additionally, in the treated splenocytes, only the crude 
fungal nanoparticle, FNP0, induced significantly higher amount of IL-10, IL-17A, 
IFN-γ, and G-CSF as compared to the untreated control, while the purified FNPs 
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didn’t show this activity. As is well known, IFN-γ is a functionally pleiotropic 
cytokine, is able to induce anti-viral activity, and has direct anti-proliferative 
effects on some tumor cell lines [133]. Hence, like G-CSF, IFN-γ is also benefit 
for antitumor immunity. Unfortunately, both purified fungal nanoparticles, FNP1 
and FNP2, didn’t have the activity on both macrophage and splenocytes. 
However, the bias in immunostimulatory activity between the purified FNPs and 
the crude FNPs may also helpful to establish the antitumor immunity in vivo, 
because the elevated level of IL-10, an anti-inflammatory, immunosuppressive 
cytokine that favors tumor escape from immune surveillance [134], was observed 
in the supernatant of splenocytes treated with the crude fungal nanoparticles, 
FNP0. It is notable that a higher amount of another cytokine, IL-17A, was 
observed from the treated splenocytes by the crude FNP0, and a low but 
significant increase in this cytokine was also observed in the treated macrophage 
by the FNP2. The role of IL-17A in anti-tumor immunity is controversial and 
remains elusive, and both pro- and anti-tumor activities of IL-17A have been 
reported [135, 136]. Overall, these results suggest that the FNPs, especially two 
purified FNPs, can potentially modulate the immune cells to an activated state to 
induce an efficient antitumor response in the cancer immunotherapy. 
Subsequently, we investigated the production of chemokines by the FNPs in both 
macrophages and splenocytes. Chemokines are small chemotactic cytokines 
which can induce migration of leukocytes, activate inflammatory responses, and 
are implicated in the regulation of tumor development and growth [137]. They can 
modulate tumor growth via regulation of tumor-associated angiogenesis, by 
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activation of host immunological responses, by direct inhibition of tumor cell 
proliferation [137], or by modulation of the neutrophils influx into the tumor tissue 
after treatment with chemo-drug during the immunochemotheray [138]. As shown 
in Figure 18C, of the panel of 12 chemokines assayed, TRANTES, MCP-1 and 
IP-10 were highly induced in the treated macrophages by the three FNPs, and 
low but statistically significant increases in MDC was also observed in the FNP2-
treated macrophages. It has been reported that RANTES enhances anti-
tumor immunity in a mouse model in part through direct T cell effector 
recruitment [78, 79]. MCP-1 has been reported to augment the antitumor effects 
by promoting lymphocyte infiltration into the tumor and subsequent cytokine 
production [139]. IP-10 has been demonstrated to elicit strong anti-tumor and 
anti-metastatic properties, and its immunological properties appear to be 
dependent on the attraction of monocytes and T lymphocytes [80], while MDC is 
chemotactic for a variety of leukocytes, and has been shown to be involved in 
Th-2 mediated cellular immunity [140]. For the activation of the splenocytes, 
except for RENTES, MCP-1, IP-10 and MDC, the elevated levels of the MIP-1a, 
MIP-1b, TARC, and KC were also observed after treatment with the three FNPs 
as compared to untreated control (Figure 18D). It has been demonstrated that 
MIP-1a showed potent anti-tumor effect after intravenous administration along 
with intra-tumor injection of certain adjuvants [141], while MIP-1b is a chemokine 
which can chemoattract T cells and NK cells, inducing efficient antitumor 
responses in a pre-established tumor model [137]. In conjunction with RANTES, 
TARC, which mediate the chemoattraction of both antitumor-specific effector T 
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cells, has been demonstrated to enhance the antitumor immune effects of GM-
CSF [142, 143]. The production of chemokine KC may amplify filtration of 
inflammatory cells, creating a more sustained antivascular action [138]. Given the 
elevated cytokines and chemokines from both macrophage and splenocytes, 
they provide the evidences that the favorable antitumor immunity in vivo could be 
established by stimulating different immunocytes, such as macrophages and 
splenocytes, with the fungal nanoparticles, especially the purified FNPs, FNP1 
and FNP2. Apart from multiple cytokines and chemokines, the bactericidal 
mediator, nitric oxide (NO), stimulated by the FNPs was further evaluated on 
both macrophages and splenocytes. As shown in Figure 18E-F, compared to the 
untreated cells, significantly elevated levels of NO were produced in both 
macrophages and splenocytes treated with the FNPs. NO is an important 
regulator and mediator of macrophage-directed cytotoxicity against tumor cells 
and microbes [119]. Significantly higher amount of NO production from the 
treated macrophages and splenocytes substantiates the potential of anti-cancer 
immunity in the cancer immunotherapy using the polysaccharide-based 
nanoparticles secreted from fungi. 
 
FNPs induce cytotoxicity in tumor cells via apoptosis and cell cycle arrest 
 
The cytotoxicity of the crude FNPs, prepared with dialysis method, has been 
demonstrated in A549 and B16BL6 cell lines in our previous study. In this work, 
after obtaining two different FNP fractions, FNP1 and FNP2, we further 
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investigated the in vitro cytotoxicity of both purified FNPs in four different tumor 
cell lines. As shown in Figure 19 A-C, the three FNP samples showed a dose-
dependent cytotoxicity against four tumor cell lines, including A549, B16BL6, 
MCF-7 and MCF-7/ADR. For the crude FNP0 sample, ~11-39% inhibition of cell 
proliferation were seen in the three tumor cell lines, A549, B16BL6 and MCF-7, 
at the concentration ranging from 1-10 µg/ml. For the purified FNP2, the inhibition 
rates of 26-37% for B16BL6 cells, 9-33% for A549 cells, and 3-30% for MCF-7 
cells were observed at the same concentration range. However, using a higher 
concentration range (2-25µg/ml), the purified FNP1 showed similar inhibition 
rates in the three tumor cells, i.e., 15-32% for B16BL6 cells, 11-28% for A549 
cells, and 3-28% for MCF-7 cells. In comparison with the FNP1 and FNP2, we 
found that the similar inhibition rates in the three tumor cells were resulted from 
different concentration ranges. The concentrations of the FNP1 were at least 2-
fold higher than those of the FNP2, indicating that the purified FNP2 have 
stronger cytotoxic activity than the purified FNP1. In addition, it is notable that all 
the three FNP samples showed lower inhibition rates (8-18% for the FNP0, 5-15% 
for the FNP1, and 9-17% for the FNP2) in the multidrug resistant cell line MCF-
7/ADR at the respective concentration ranges. The lower inhibition rates here 
suggest that the FNPs only possess mild to moderate cytotoxic activity and the 
maximal concentration tested in this study is still not enough to effectively inhibit 
the proliferation of the resistant cells.  
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Figure 19 Cytotoxicity of the FNPs and the DOX-FNPs complexes against multiple cell 
lines. 
(A-C) The cytotoxicity of the FNPs against four tumor cells, i.e. human non-small-cell lung cancer 
A549 cells, mouse melanoma B16BL6 cells, human breast cancer MCF-7 cells and the multidrug 
resistant cell line MCF-7/ADR; (D-F) The cytotoxicity of the FNPs against mouse embryo 
fibroblast cell line NIH3T3; (G-J) The cytotoxicity of the DOX-FNP complexes against four tumor 
cell lines (A549, B16BL6, MCF-7 and MCF-7/ADR). The sigmoidal dose-response curves were 
fitted using OriginPro 8.0.  
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Even for the sensitive tumor cells, the highest inhibition rates were still less than 
40% at the maximal concentration of 10µg/ml for FNP2 or 25µg/ml for FNP1. The 
mild to moderate cytotoxic activity of the FNPs were further evidenced by an in 
vitro biocompatibility test using NIH3T3 cell line. NIH3T3 is a mouse embryo 
fibroblast, which were commonly used in the biocompatibility evaluation of 
nanomaterials [120, 144]. Less than 20% inhibition rate were seen in NIH3T3 
cells treated with the three FNPs at the respective concentration ranges (Figure 
19D-F), suggesting that the FNPs didn’t have strong cytotoxic effect against 
normal cells, but had slightly higher cytotoxicity against tumor cells, especially 
towards the sensitive tumor cells.  
Even though the FNPs only possess mild to moderate cytotoxic activity, given 
that the FNPs induced the secretion of multiple proinflamatory cytokines and 
chemokines from immunocytes (Figure 18), we believe that they are a potential 
immunomodulator of biological responses in the adjuvant antitumor therapy in 
which the synergistic effect could be reached between the mild cytotoxic activity 
and the immunostimulatory activity. For the purified FNPs, we have 
demonstrated a similar immunostimulatory activity between the FNP1 and FNP2, 
inducing almost same levels of cytokines and chemokines from immunocytes 
(Figure 18). However, as far as the cytotoxic activity concerns, the FNP2 
showed around 2-fold stronger activity in the tumor cells tested in this study 
(Figure 19A-C). To better understand the difference in the cytotoxicity between 
both purified FNPs, we further investigated the apoptotic effect and cell cycle 
arrest in the tumor cells treated by both purified FNPs. As expected, the purified 
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FNP2 induced strong apoptosis in the A549 cells and B16BL6 cells after an 48-h 
incubation, and the crude FNP0 had similar but weaker apoptosis induction in 
both tumor cells; however, the purified FNP1 couldn’t induce significantly 
apoptotic effect in A549 tumor cells and induced only slight apoptotic effect in 
B16BL6 cells (Figure 20A-B), which may explain the weaker cytotoxicity of the 
FNP1 as compared to the FNP2. The cell cycle arrest analysis using A549 and 
B16Bl6 cells treated with both purified FNPs substantially agrees with the 
apoptosis assay. As shown in Figure 20C-D, the FNP2 arrested the cell cycle at 
sub G0/G1 phase in both tumor cells after an 24-h incubation, and the crude 
FNP0 showed the similar activity in both tumor cells. A significant increase in the 
sub G0/G1 peak, which corresponds to apoptotic cells, represents that the tumor 
underwent apoptosis [145, 146]. However, the purified FNP1 couldn’t significantly 
induce the cell cycle arrested at the sub G0/G1 phage, indicating that there 
should be different mechanisms for the cytotoxicity of the purified FNP1 and 
FNP2, although they showed similar immunostimulatory activity. 
 
Formation of pH-responsive complexes by efficiently binding DOX to FNPs 
Utilizing the purified FNPs as a nanocarrier for chemo-drug delivery is the 
purpose of this study to implement the synergistic effect between the 
immunostimulation from FNPs themselves and cytotoxicity from both FNPs and 
chemo-drugs. For such a purpose, DOX was used as a model chemo-drug in this 
study to form a DOX-FNP nanocomplex.  
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Figure 20 Apoptosis (A-B) and cell cycle arrest (C-D) in human non-small-cell lung cancer 
A549 cells (A and C) and mouse melanoma B16BL6 cells (B and D) induced by the FNPs.  
The cells were treated with the FNPs at the GAG concentration of 10µg/ml for 48 h (apoptosis 
assay) or 24h (cell cycle analysis). For apoptosis assay, the fragmented DNA was stained with 
TUNEL method (M&M Section 2.6) and then measured by flow cytometry. For cell cycle analysis, 
the cells were stained with PI, and then measured with flow cytometry. 
  
(C) 
(D) 
(A) 
(B) 
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The physical characteristics, in vitro cytotoxicity and immunochemotherapeutic 
effect of the complexes were further evaluated. As shown in Figure 21A, DOX 
could be efficiently bound to both fungal nanoparticle fractions, FNP1 and FNP2, 
when mixing DOX and the FNPs in 20mM HEPES buffer at pH 7.0. Due to 
negative surface charges for both FNP1 and FNP2 (Table 4), DOX, carrying 
positive charges from deprotonation of the amino group at pH7.0 in HEPES 
buffer [147], could be bound to FNPs via electrostatic interactions. The binding 
between DOX and FNPs was so highly efficient that leads to formation of 
precipitates overnight after centrifugation at 10,000 rpm for 10min (Figure 21A). 
The collected precipitates were then dispersed in PBS buffer (pH 7.0) and nano-
sized DOX-FNP complexes were formed. As shown in Table 2, for both 
complexes, DOX-FNP1 and DOX-FNP2, the hydrodynamic diameters, measured 
by DLS analysis, were less than 200nm, which was slightly increased compared 
to the blank FNPs (Table 4). The morphology of the dispersed DOX-FNP 
complexes in the PBS buffer was also imaged with AFM, and both DOX-FNP 
complexes were spheroidal nanoparticles with diameters of less than 200 nm 
(Figure 21 C-D), similar to the blank FNPs (Figure 16). In addition, from Table 5, 
there were significant decreases in zeta potentials for the DOX-FNP complexes 
as compared to both blank FNPs, indicating a direct association of DOX with the 
FNPs via electrostatic interactions [148]. More importantly, the entrapment ratio 
of DOX in the FNPs was as high as ~72%-77%, and the precipitated DOX-FNP 
complexes with such a high drug loading were demonstrated to be stable after 
the nano-sized DOX-FNP complexes were formed in the PBS buffer.  
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Figure 21 Characterization of the DOX-FNP complexes and pH-responsive release of DOX 
from the complexes. 
(A) The DOX-FNP complexes were precipitated in 20mM HEPES buffer (pH7.0) after 
centrifugation at 10,000 rpm for 10min; (B) Purification of the precipitated DOX-FNPs complexes 
from free DOX using SEC column after being well dispersed in PBS buffer (pH7.4); (C) AFM 
images of the DOX-FNP1 complexes; (D) AFM images of the DOX-FNP2 complexes; (E) pH-
responsive release of DOX from the complexes. 
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Table 5 Physical characteristics and cytotoxicity of the DOX-FNP 
complexes 
 
Size 
Zeta 
potential 
Entrapment 
ratio 
IC50 (nM) 
A549 B16BL6 MCF-7 MCF-7/ADR 
DOX-
FNP1  
194.5±79.5 -22.2±7.5 77.4%±2.4% 1170.60±92.33 494.87±38.00 1830.53±270.47 5464.57±16.87 
DOX-
FNP2 
186.9±89.7 -24.24±6.0 72.2%±0.7% 599.34±15.85 209.63±23.72 355.71±23.06 3522.55±110.03 
Free 
DOX 
- - - 1052.54±67.58 308.82±26.55 648.39±75.77 4177.36±116.12 
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As shown in Figure 21B, the amount of DOX dissociated from the complexes in 
the PBS buffer was as low as ~20%. As such, the DOX-FNPs complexes 
dispersed in PBS buffer were directly used as a nano-sized antitumor agent 
without further purification to remove free DOX for the following studies, including 
uptake, cytotoxicity and immunochemotherapeutic effect.  
In principle, pH-responsive release of DOX was expected from the nano-
complexes formed via an electrostatic driving force between DOX and 
nanoparticles, which could provide a stimulus-responsive release mechanism 
after internalization by tumor cells or penetration into the tumor tissue in vivo 
[149]. The release profiles of DOX from both complexes at different pHs were 
further evaluated by immersing the dialysis tubes in large volume centrifuge 
tubes containing 6 ml of release buffers with different pH values. As shown in 
Figure 21E, a free DOX control confirmed that the dialysis membrane tubing with 
300K MWCO in this study couldn’t restrict diffusion of the released drugs into the 
bulk release media in which the sink condition was established, and they were 
able to reach 100% release after 5 h. However, the release of DOX from both 
complexes at different pH couldn’t reach a plateau until at least 9-10 h. The total 
released drug from both DOX-FNP complexes was significantly different under 
different pH conditions (Figure 21E). Up to ~55% and ~65% of total drug were 
released at the physiological pH 7.4 for the DOX-FNP1 and DOX-FNP2 
complexes, respectively; however, around 80% of total drug released at pH 5.5 
were observed for both complexes. More importantly, the release rate of drug 
from both complexes increased with decreasing in the pH of release medium, 
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indicating a pH-sensitive release behavior with accelerated release of DOX in an 
acidic environment from both complexes. This favorable property is believed to 
facilitate passive tumor targeting and endosome escaping since the interstitial 
space of solid tumors and intracellular endosome compartments have a lower pH 
value [56].  
 
Cytotoxicity, uptake and intracellular distribution of DOX-FNP complexes in 
tumor cells 
Fungal nanoparticles have been demonstrated to be cytotoxic in our previous 
study [114]. In current work, we also confirmed that both purified fractions, FNP1 
and FNP2, had mild to moderate cytotoxic activity against multiple tumor cell 
lines. However, compared to the FNP1, the FNP2 itself at the same GAG 
concentration had around 2-fold increase in cytotoxicity against 4 tumor cell lines 
tested in this study (Figure 19 A-C). In our early study, we demonstrated that 
there was synergistic cytotoxicity exerted by covalently conjugating DOX with 
FNPs via amide bond [114]. As such, a synergistic cytotoxic effect between DOX 
and the FNPs when forming the physical complexes via the electrostatic 
interactions is anticipated in this study. As expected, the DOX-FNP2 complexes 
showed significantly higher cytotoxicity against 4 tumor cells than free DOX after 
a 48-h incubation (Figure 19 G-J). The IC50 of the DOX-FNP2 complexes and 
free DOX are listed in Table 5. For A549, B16BL6 and MCF-7 cell lines, the IC50 
for the DOX-FNP2 complexes was ~1.5-1.8 fold lower than free DOX; even for 
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the multidrug resistant cell line MCF-7/ADR, the IC50 for the DOX-FNP2 was still 
~1.2 fold lower than free DOX. These data demonstrate a synergistic cytotoxic 
effect when DOX was bound to one fraction of the FNPs, i.e., FNP2, even 
against the resistant tumor cell line. As shown in Figure 5G-J, at the respective 
IC50 values of free DOX (Table 5), free DOX inhibited cell proliferation by 50%, 
whereas the DOX-FNP2 complexes showed ~62%-75% inhibition against the 
four tumor cells. According to a ~72% entrapment ratio for the DOX-FNP2 
complexes (Table 5), the concentration of the FNP2 in the complexes at the 
respective IC50 values of free DOX for the A549, B16Bl6 and MCF-7 cells was 
calculated to be less than 0.25 µg/ml of GAG concentration, and for the resistant 
MCF-7/ADR cells less than 1.0µg/ml of GAG concentration. From Figure 19A-C, 
almost no significant inhibition effect on four tumor cells was observed at that 
concentration for FNP2 itself, indicating that DOX and FNP2 in their physical 
complexes via the electrostatic interactions exerted synergistic cytotoxic effects 
and led to the IC50 values 1.2-1.8 fold lower against four different tumor cells 
(Table 5). 
Unexpectedly, the cytotoxicity of the DOX-FNP1 complexes was similar or even 
lower than free DOX in the four different cell lines, which is completely different 
from the DOX-FNP2 complexes. As shown in Table 5, the IC50 values for the 
DOX-FNP1 complexes were ~1.1-2.8 fold higher than free DOX against 4 tumor 
cell lines, indicating that there is no obvious synergistic effect between DOX and 
the FNP1 upon forming the physical complexes. We postulate that the difference 
in the cytotoxicity of both complexes was due to their different cytotoxicity of the 
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FNPs themselves, because the FNP1 showed at least 2-fold higher cytotoxicity 
against different tumor cells than the FNP2 at the same GAG concentration 
(Figure 19A-C). Presumably, the differences in the cytotoxicity of the FNPs 
portend the different chemical structures for both FNP1 and FNP2 fractions, 
including polysaccharide chain, monosaccharide composites and linkages, uronic 
acid content, sulfation degree, and possible core proteins. Although the similar 
chemical components were characterized for both FNPs in the Table 1 and 
Figure 17, showing that the polysaccharide including acidic GAG and neutral 
polysaccharides were main components in both FNPs, the specific chemical 
structures for both FNPs still remained elusive. We presume that different 
chemical structures in both purified FNPs eventually lead to different cytotoxicity 
of FNPs themselves and the DOX-FNP complexes, as well as the different 
physical properties including zeta potential and morphology (Table 4, Figure 16 
and 21). 
In order to elucidate whether the different cytotoxicity between the DOX-FNP1 
and DOX-FNP2 complexes is related to DOX uptake and intracellular distribution 
after forming the complexes, we quantitatively analyzed the cell-associated DOX 
fluorescence intensity using flow cytometry after treatment of both tumor cell 
lines, A549 and B16BL6, with both complexes. As shown in Figure 22, for both 
tumor cells, there was no significant difference in the DOX fluorescence for both 
complexes and free DOX at the DOX concentration of 10 μM after a 4-h 
incubation, indicating that DOX uptake wasn’t impeded upon the formation of the 
DOX-FNP complexes via the electrostatic interactions.  
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Figure 22 Quantitative analyses of DOX uptake by human non-small-cell lung cancer A549 
cells (A-B) and mouse melanoma B16BL6 cells (C-D).  
Both cells were treated with the DOX-FNP complexes or free DOX at DOX concentration of 10 
μM for 4 h, and then the mean DOX fluorescence associated with the cells were measured by 
collecting 20 000 events for each sample.  
  
(A) (B) 
(C) (D) 
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On the other hand, these data substantiate that the different cytotoxicity of both 
complexes was from their different cytotoxicity of the FNPs themselves rather 
than the increase in the DOX uptake enhanced by the FNPs in the tumor cells.  
To further observe intracellular distribution of both DOX-FNP complexes, the 
nuclei and endolysosome were labeled with a nucleus-specific dye, Hoechst 
33342 (blue), and an acidic endolysosome-specific dye, LysoTracker green 
DND-26, respectively. Before investigating both DOX-FNP complexes, we first 
tested if the FNPs themselves could be efficiently internalized in the tumor cells. 
For such a purpose, the FNPs were conjugated with FITC (Table 6), and then 
incubated with A549 tumor cells for 4 hours. As shown in Figure 23, both purified 
FNPs, FNP1 and FNP2, were confirmed to be efficiently taken up by the tumor 
cells after a 4-h incubation. The internalization of FNPs themselves by tumor 
cells substantially indicates that the FNPs themselves could mediate the uptake 
and distribution of DOX in tumor cells via the DOX-FNP complexes, instead of 
free DOX released from the complexes. Upon confirming the uptake of the FNPs 
themselves by tumor cells, we imaged sub-cellular distribution of the DOX-FNP 
complexes in both tumor cells, A549 and B16BL6. As shown in Figure 24, the 
confocal analysis showed that different intracellular distribution of both DOX-FNP 
complexes and free DOX was observed in both tumor cells after a 4-h treatment. 
The majority of DOX in both cells incubated with both complexes were 
predominantly distributed in the endolysosomal compartment, while most of the 
free DOX was located outside the organelle.  
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Table 6 Characteristics of the FITC-labeled FNPs* 
 
Size (nm) 
Zeta potential 
(mV) 
Conjugation ratio (%) 
FITC-labeled FNP1  246.9±42.6 -19.9±3.8 0.031%±0.007% 
FITC-labeled FNP2 252.5±60.6 -27.1±0.9 0.025%±0.009% 
*Note: The preparation of FITC-labeled FNPs was detailed in the M&M Section 2.10. 
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Figure 23 Internalization of the purified FNP1 (A) and FNP2 (B) themselves in human non-
small-cell lung cancer A549 cells.  
Both FNPs were labeled with FITC and then incubated with A549 cells at the FITC concentration 
of 2ng/ml for 4h. For confocal imaging, the nuclear-specific dye Hoechst 33342 was used to label 
the tumor cell nuclear. The cells were also recorded in the bright-field for the morphology. Scale 
bars represent 10 μm. 
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Figure 24 Confocal analysis of intracellular distribution of the DOX-FNP complexes at the 
DOX concentration of 10 μM in human non-small-cell lung cancer A549 cells (A) and 
mouse melanoma B16BL6 cells (B).  
The cells were incubated with the samples at 37 °C in 5% CO2 for 4 h, and then 100 nM 
Lysotracer Green DND-26 and 4 μM Hoechst 33342 were added for 30 min incubation prior to 
imaging by confocal microscopy. Scale bars represent 10 μm. 
(A) DOX Lysotracker Green  Hoechst Merge 
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As is well known, major nanoparticles internalized via endocytosis were mainly 
found within endosomes or lysosomes [150]. Thus, we presume that the DOX-
FNP complexes might be internalized by endocytic pathway in both tumor cell 
lines. In this study, the DOX-FNP complexes were demonstrated to have a pH-
sensitive release behavior with accelerated release of DOX in an acidic 
environment (Figure 21B), which facilitate DOX escaping from endosome or 
lysosomes after internalization of both complexes in tumor cells. Hence, we 
believe that the different distribution couldn’t be another cause that led to the 
different cytotoxicity for both DOX-FNP complexes. Overall, the results here 
demonstrate that even though there was a different sub-cellular distribution, the 
formation of the DOX-FNP complexes did not decrease DOX uptake by both 
tumor cell lines, which further supports that the different cytotoxicity of both 
complexes was from their different cytotoxicity of the FNPs themselves against 
tumor cells. 
  
Immunochemotherapeutic activity of DOX-FNP complexes in an in vitro co-
culture system 
After demonstrating the different cytotoxicity of both DOX-FNP complexes 
against tumor cells, the hypothesis of combined immunochemotherapy using the 
complexes was further confirmed by the co-culture analysis. The co-culture study 
is an in vitro model system for mimicking in vivo situation [98, 103]. For such a 
purpose, B16BL6 tumor cells were first labeled with CFSE, and co-incubated with 
splenocytes isolated from C57BL/6 mice; the co-cultures were then incubated 
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with either DOX-FNP complexes, or free DOX at the DOX concentration of 1µM 
for 24h. As expected, significantly higher death of the cancer cells was observed 
with the treatment of the DOX-FNP2 complexes as compared to free DOX or the 
DOX-FNP1 complexes (Figure 25), which is consistent with the data in the direct 
cytotoxicity experiment using MTT assay (Figure 19G-J and Table 5). As the 
DOX-FNP2 complexes had both cytotoxic and immunostimulating activity, these 
two might be cooperating with each other to produce a synergistic effect, 
resulting in higher death in the co-culture cells treated with the complexes. 
Interestingly, compared to the direct cytotoxicity experiment where the DOX-
FNP1 complexes had lower cytotoxicity than free DOX (Figure 19G-J and Table 
5), in the co-culture experiment where a mixed culture of cancer cells and 
splenocytes were treated, the DOX-FNP1 complexes unexpectedly enhanced 
tumor cell death as compared to free DOX alone. In this co-culture experiment, 
higher death of the cancer cells exerted by both complexes, especially the DOX-
FNP1 complexes could be attributed to the immune stimulatory activity of the 
FNPs as both FNPs have been shown to induce the secretion of multiple pro-
antitumor cytokines and chemokines from splenocytes, such as TNF-α and MIP-
1a, which has direct cytotoxic activity. Overall, the enhanced tumor cell death by 
both complexes in this experiment confirmed the potential in combined caner 
immunochemotherapy using the DOX-FNP complexes in vivo in the future.  
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Figure 25 Chemo-immunotherapeutic activities of both DOX-FNP complexes in an in vitro 
experimental system where B16BL6 tumor cells were first labeled with CFSE and then co-
cultured with the splenocytes derived from C57BL/6 mice.  
The co-cultures were treated with free DOX (B) and both DOX-FNP complexes(C-D) at the DOX 
concentration of 1µM, incubated for a 24-h, and then the death of tumor cells was determined by 
the PI uptake method using flow cytometry after gating on the CFSE labeled cancer cells. The 
untreated co-cultured cells were used as a negative control (A). Statistical analysis of the mean 
DOX fluorescence associated with the cells was performed, and significant differences (P<0.05) 
between different treatments were observed (E). 
(A) (B) 
(C) (D) 
(E) 
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Conclusions 
 
The purpose of this study was to evaluate the immunostimulatory activity, dissect 
the mechanism of the cytotoxicity, and explore the potential in cancer 
immunochemotherapy using the FNPs as a multifunctional nanocarrier. For such 
a purpose, we first established a new isolation procedure, SEC-WAX-SEC, to 
purify the FNPs, by which two purified FNP fractions, FNP1 and FNP2, were 
prepared. AFM imaging and DLS analysis showed that both purified FNPs had a 
reduced diameter of 100-200 nm compared to the crude FNPs. SDS-PAGE and 
chemical assays showed that polysaccharide including glycosaminoglycan were 
main constituents in the purified FNPs. They were demonstrated to enhance the 
secretion of multiple proinflammatory cytokines and chemockines from 
macrophages and splenocytes, measured by ELISArray, suggesting the efficacy 
of the FNPs as an immunomodulator of biological responses in the adjuvant 
antitumor therapy. MTT assay showed that both purified FNPs had mild to 
moderate cytotoxicity against multiple tumor cells but the FNP2 had stronger 
cytotoxic activity than the FNP1. The apoptotic assay and cell cycle analysis 
further demonstrated that the FNP2, not the FNP1, could inhibit cell proliferation 
via inducing apoptosis and arresting tumor cells at sub G0/G1 phase, which may 
explain the difference in the cytotoxicity between both FNPs. For testing the 
combined cancer therapy, both FNPs formed the pH-responsive nanocomplexes 
with chemo-drug, DOX, via the electrostatic interactions. Upon binding of DOX to 
the FNPs, it was demonstrated that the DOX-FNP2 complexes had higher 
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cytotoxic activity than free DOX against multiple tumor cells, while the cytotoxic 
activity of the DOX-FNP1 complexes was weaker than free DOX. Interestingly, in 
a co-culture experiment where splenocytes were co-cultured with tumor cells, 
both nanocomplexes demonstrated higher antitumor activity than free DOX, 
suggesting the synergistic effect between the immunostimulation of the FNPs 
and cytotoxicity of the nanocomplexes in vitro. In conclusion, this work developed 
a one-step therapy containing agents for both immuno- and chemotherapy using 
the natural-based nanoparticles as a multifunctional nanocarrier, which may open 
a new avenue for combined cancer therapy in the future. 
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CHAPTER IV  
BIO-SYNTHESIS OF GOLD NANOPARTICLES USING ENGLISH 
IVY (HEDERA HELIX) 
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Introduction 
 
Gold nanostructures have been used in many applications, including waveguides 
for electromagnetic radiation [151], optical coatings [11], Surface Enhanced 
Raman Spectroscopy (SERS) [152-154], and cancer diagnostics [155-159]. 
Consequently, various physical, chemical and biological methods have been 
reported to produce gold nanostructures [160-163]. Gold nanoparticles (AuNPs) 
can be produced using a multitude of chemical and physical processes; however, 
these approaches are often costly and have environmental risks associated with 
their production. To reduce the use of toxic chemicals used in typical AuNP 
synthesis, researchers are actively investigating alternative synthesis methods 
using biological materials (proteins, polysaccharides, polyphenol, etc.) for green-
synthesis of gold nanoparticles [164-167].  
Recently, several plants have been reported to efficiently synthesize gold and 
silver nanoparticles [168-170]. For example, the leaf extract from tea [171], 
lemongrasss [11], Aloe vera [172], Fagopyrum esculentum  [165], and the fruit 
extract of Embica officinalis [173], and Tanacetum vulgare [174] have 
demonstrated the potential for reducing gold ions into AuNPs. According to these 
biosynthetic procedures, AuNPs could be obtained after simply mixing HAuCl4 
solution with the plant extract [166]. Multiple reductases and chemical reducing 
agents from the extracts have been found to be responsible for the formation of 
these nanoparticles [9]. For instance, NADPH, a common biological coenzyme 
[175], proteins, polyphenols, and carbohydrates from plant extracts have been 
suggested to be involved in the synthesis of AuNPs [9]. However, the exact 
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mechanism of this synthesis is still not completely understood, due to the large 
number of components in the plant extracts, any of which could be involved in 
the synthesis. The multitude of chemical compounds found in plant extracts also 
leads to the formation of various species of AuNPs from a single reaction. 
Synthesized AuNPs often vary in size, shape, and morphology, and further 
processing must be conducted to isolate a single species [13, 164, 166, 176-178]. 
Despite the ease of AuNP synthesis using plant extracts, a major hurdle exists in 
developing a sustainable procedure for the production of AuNPs. Previous 
studies have attempted to resolve this challenge by using live plants to 
synthesize AuNPs; however, most of these procedures involve harvesting AuNPs 
from the plant tissue, which introduces increased complexity due to the limited 
amount of AuNPs relative to the large plant biomass [48, 49]. Of greater concern 
for sustainability, is that the plant must be sacrificed to harvest the AuNPs, which 
means that plant will be removed from the production system. This will lead to 
the increased costs, and delay the production of the nanoparticles.   
In this work, both a sustainable biological synthesis method and a rapid synthesis 
procedure have been developed for continuous and scalable manufacturing of 
gold nanoparticles. The proposed approaches allow for the production of AuNPs 
out of aqueous HAuCl4 with either actively growing English ivy (Hedera helix) 
shoots or the extract formed from the adventitious roots. The synthesized AuNPs 
were easily collected from both methods requiring minimal time and effort. By 
replacing the HAuCl4 solution every 24 hours, in the sustainable production 
system, AuNP synthesis was carried out over a period of 30 days using the same 
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raw material. The development of a robust and sustainable procedure for 
synthesizing AuNPs with a reduced environmental impact represents an 
important step forward in scalable green production of metal nanoparticles. 
Furthermore, the use of various molecular weight fractions of the adventitious 
root extract demonstrated the ability to rapidly form smaller nanoparticles than 
the sustainable method. Using these two methods, we have demonstrated how 
plant materials represent an efficient ―green‖ solution to address the growing 
need for AuNP synthesis.   
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Materials and methods 
Chemicals and Reagents 
Chemical analysis grade hydrogen tetrachloroaurate (III) (HAuCl4), 1,9-Dimethyl-
Methylene Blue (DMMB) ), chondroitin sulfate (CS), and phosphate buffered 
saline (PBS) were purchased from Sigma-Aldrich. For protein quantification, the 
BCA Protein Assay Kit (Pierce) was purchased from Thermo Scientific. Dialysis 
membranes were purchased from Spectrum Laboratories, Inc (Rancho 
Dominguez, CA). Ivy shoots and adventitious roots were donated from Swan 
Valley Farms (Bow, WA). 
Method One: Sustainable synthesis of AuNPs using live shoots 
 
Upon receipt, live ivy shoots were cut to lengths of 15 cm, leaving one attached 
leaf on the apical end of the stem. After sterilization and treatment with auxins, 
four shoots were placed into Magenta GA7 (MAG) boxes and held upright by 
placing them through holes cut into the lids. After 24 hours, the boxes were 
transported to a windowsill, where the nanoparticle synthesis was conducted. To 
initiate nanoparticles synthesis, aqueous HAuCl4 was added to the 50 ml of 
water present in the MAG boxes to achieve concentrations of 0, 0.025, 0.05, 0.1, 
0.2, 0.5, 1 and 5 mM. The shoots were exposed to these concentrations for 24 
hours, before the solution was removed to test for nanoparticle production. After 
collecting the solution after 24 hours, fresh HAuCl4 solution at the same 
concentration was added back to the MAG boxes. This method was repeated for 
the duration of the study. To concentrate any nanoparticles present in the 
solution, the solution was centrifuged at 14,000 rpm for 10 min. The supernatant 
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was then removed, and DI water was added to the precipitate. This procedure 
was repeated three times to remove soluble factors present in the solution, 
including secreted proteins, polysaccharides, and excess HAuCl4. A schematic 
for this method is shown in Figure 26A. 
Method Two: Synthesis of AuNPs using adventitious root extract 
 
Upon receipt, adventitious roots were homogenized in a minimal volume of water, 
creating a dense solution. This solution was centrifuged at 4,400 rpm for 5 min to 
remove large tissue debris from the homogenization. The resulting light brown 
supernatant was then transferred to dialysis tubing with a molecular weight cutoff 
value (MWCO) of 3.5 kDa, and dialyzed overnight against DI water. After dialysis, 
the solution outside of the dialysis tubing was collected and labeled as Solution I. 
The solution remaining in the tubing was then transferred to new tubing and 
dialyzed at 12 kDa. As indicated above, the solution outside of the tubing was 
collected and labeled Solution II, followed by a final dialysis through dialysis 
tubing with a cutoff value of 300 kDa. The final solution outside of the membrane 
was labeled as Solution III, and the solution remaining in the tubing was labeled 
Solution IV. Prior to analysis, the extracts were freeze dried and re-suspended in 
DI water. To synthesize gold nanoparticles from the ivy rootlet extract solutions, 
500 µl of each solution (I-V) was transferred into a clean microfuge tube and 
aqueous HAuCl4 was added to a final concentration of 0.5 mM. The mixture was 
then vortexed, and reacted at room temperature. To concentrate the synthesized 
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Figure 26 Schematic diagrams of two different methods used in this study. 
A, Schematic of the sustainable biosynthesis and stability of AuNPs in ivy shoots culture 
system.HAuCl4 solution was added to the culture media and the gold nanoparticles could be 
collected after 24 hours. And then fresh HAuCl4 solution was added back for sustainable 
synthesis of AuNPs; B, Procedure for the ivy rootlet extracts preparation, separation and gold 
nanocrystal synthesis. Dialysis tubings with different molecular weight cutoff value (M.W.CO) of 
3500 Da, 12,000 Da and 300,000 Da were used to separate different fractions from ivy rootlet 
extract. And then the four factions were used to synthesize gold nanoparticles.  
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gold nanoparticles, the solutions were centrifuged and washed as described 
above. A schematic for this method is shown in Figure 26B. 
Characterization of the gold nanoparticles 
 
A variety of techniques were used to determine if AuNPs were formed using the 
two methods described above. First, the Surface Plasmon Band (SPB), 
generated by the formation of AuNPs was examined using a Thermo Scientific 
Evolution 600 UV-Vis Spectrophotometer (Waltham, WA). After confirming the 
presence of SPB, the samples were analyzed by DLS and Zeta Potential 
analysis, using a Zetasizer Nano (Malvern Instruments Ltd, Worcestershine, UK), 
to determine the size distribution of the nanoparticles, and also the stability of the 
nanoparticles in solution. In order to characterize the morphology of the 
synthesized AuNPs, 10 µl of solution was air-dried onto a piece of silicon wafer 
and scanned at high resolution with a LEO 1525 FE-SEM equipped with a 
Gemini Emission Column. Simultaneously, energy dispersive x-ray spectroscopy 
(EDS) was conducted on the nanoparticle images to ensure that the 
nanoparticles were Au. The amount of protein present in the culture water was 
also characterized using a bicinchoninic acid (BCA) protein assay kit (Pierce) 
following the manufacturer’s instructions. Similarly DMMB was used to measure 
the concentration of proteoglycan in solution using standard methodology [179].  
 
To evaluate the intracellular uptake of the synthesized AuNPs, pelleted AuNPs 
were resuspended in PBS and added to cell culture medium. The AuNPs 
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containing media were then incubated with mouse MC3T3 cells for 4 hours. After 
incubation, cells were washed three times with PBS buffer and incubated in fresh 
α-MEM medium supplemented with 10% fetal bovine serum (FBS), 1.0 × 105 U/l 
penicillin (Sigma) and 100 mg/ml streptomycin (Sigma) overnight. The 
intracellular uptake of the AuNPs was observed using the Cytoviva™ system 
attached to a Nikon Eclipse E600. 
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Results 
UV-Vis analysis of AuNP Formation (Method One) 
 
After a few hours, the culture solution changed in color from clear to red, violet, 
dark purple, and light purple, depending on the concentration of HAuCl4 (insert in 
Figure 27A). At this point the solution was removed for analysis of the AuNPs 
formed during, and fresh HAuCl4 solution was added back to the GA7 boxes. 
Analysis of the UV-Vis spectra of the solution collected after incubation with 
HAuCl4 concentrations of 0.025, 0.05, 0.1, 0.2, 0.5 and 1 mM showed a SPB 
around 550 nm, specific for AuNPs [180]. No SPB was present at HAuCl4 
concentrations of 0 and 5 mM (Figure 27A). While the SPB appeared at the 
same absorbance for AuNP forming concentrations, there was a significant 
difference in the width of the SPB at different concentrations of HAuCl4 solution. 
To test the sustainability of the AuNP synthesis procedure described above, the 
HAuCl4 solution was removed and replaced with fresh solution every 24 hours 
and UV-Vis spectroscopy was conducted on the freshly removed solution to 
determine if AuNPs were still being produced. Figure 27B shows that at 0.1 mM 
HAuCl4, AuNPs were formed every 24 hours continuously over a 10 day period. 
Based on the Beer-Lambert law, the UV- Vis absorbance of a solution is directly 
proportional to the concentration of the absorbing species in the solution and the 
path length [181]. In our experiments, the path length was kept constant, thus the 
concentration of AuNPs in the solution, can be linearly correlated to the 
absorbance of the AuNP solution. We used this relationship to determine the 
relative concentration of AuNPs at each time interval, and to calculate the  
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Figure 27 UV absorption spectra of gold nanoparticles synthesized. 
A. UV-vis absorption spectra of gold nanoparticles synthesized in 0.025, 0.05, 0.1, 0.2, 0.5, 1 and 
5mM aqueous AuCl4- in ivy culture system in the 1st day. The inset photo showed gold 
nanoparticles formed with different concentration of aqueous AuCl4- (a. 1 mM, b. 0.5 mM, c. 0.2 
mM, d. 0.1 mM, e. 0.05 mM, f. 0.025 mM) in ivy culture system. B. UV-vis absorption spectra 
recorded the gold nanoparticles formation in live ivy culture system, rich with 0.1 mM aqueous 
AuCl4
-
 environment from the 1st day to the 10th day respectively (Each curve experienced 24 
hours reaction time). 
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efficiency of the synthesis procedure over time. From the spectral data, the 
efficiency of AuNP production remained high for the first 5 days, and decreased 
from day 6 -30. Despite the decrease in efficiency, AuNPs could still be obtained 
from the production system for greater than 30 days, demonstrating the 
sustainability of this method. The same sustainable property was also observed 
at lower HAuCl4 concentrations (0.025 mM, 0.05 mM) (Figure 28A-B). In the 
presence of higher concentrations of HAuCl4 solution (0.5 mM, 1 mM) the 
decrease in production efficiency was more obvious compared to the lower 
concentrations (Figure 28C-D), especially at 1 mM HAuCl4. At this high 
concentration of HAuCl4 some toxicity may occur in the ivy shoots, which 
decreases the rate of the overall production. 
UV-Vis analysis of AuNP Formation (Method Two) 
 
Solutions I-IV were reacted with 0.5 mM HAuCl4 solution at room temperature, 
as described in the Material and Methods section. A characteristic surface 
plasmon resonance band (SPR) for gold nanoparticles at 500-600 nm was 
detected in all four samples (I-IV) (Figure 29), confirming the synthesis of gold 
nanoparticles in these solutions.  
Morphological analysis of AuNPs in Solution 
 
DLS and Zeta potential analysis was used to analyze the size of the AuNPs in 
solution, and to determine the stability of nanoparticles. DLS of the AuNPs 
formed using Method One, indicated that the average size of the AuNPs 
increased from 10 to 300 nm with an increasing concentration of HAuCl4 from  
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Figure 28 UV-Vis absorption spectra recorded the gold nanoparticles formation in live ivy 
culture system. 
UV-Vis absorption spectra recorded the gold nanoparticles formation in live ivy culture system, 
rich with different concentration of aqueous AuCl4- environment (A, 1 mM; B, 0.5 mM; C, 0.05 
mM; D, 0.025 mM) from the 1st day to the 10th day respectively. 
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Figure 29 UV/Vis spectra of gold nanoparticles synthesized by different ivy rootlet extract 
solutions. 
UV/Vis spectra of gold nanoparticles synthesized by different ivy rootlet extract solutions.  Gold 
nanoparticles from solution I has a larger absorbance value at λmax, indicating more gold 
nanoparticles synthesized from solution I. Gold nanoparticles from solution III and IV have more 
absorbance over 720 nm, suggesting more nanoplates or clusteres in the solution III and IV.  
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0.025 to 2 mM. This agreed well with the red-shift of the UV-Vis spectra with 
higher concentrations, as shown in Figure 27. The size distribution of gold 
nanoparticles, formed from 0.1, 0.5 and 1 mM HAuCl4, were measured by DLS 
and displayed in Figure 30A-C. Based on the Zeta potential analysis, none of the 
solutions containing the AuNPs, formed using Method One, was stable in water, 
with zeta potentials ranging from -18.1 to -33.5 mV. This analysis was not 
surprising, since the AuNPs were observed to sediment from solution, and could 
easily be centrifuged at a low speeds. 
The size distributions of AuNPs synthesized using Method Two, were also 
analyzed by DLS and Zeta potential analysis.  AuNPs formed using Solution I 
and II showed smaller average sizes compared with solution III and IV (Figure 
30D-G). A significant difference was observed in the Zeta potential of the AuNPs 
synthesized from the different solutions. Solution I, with a Zeta potential < -30 mV 
was moderately stable in solution. In solution II, the Zeta potential increased to > 
-30 mV, suggesting an instability of the AuNPs in solution. The Zeta potential 
further increased in solution III and IV to larger than -15 mV. Precipitates in these 
two solutions could be clearly observed, indicating the instability of the AuNPs 
and the aggregation of these AuNPs. 
Morphological analysis of dry AuNPs 
 
To examine the effect of the HAuCl4 concentration on the morphology of the 
nanoparticles produced, SEM was conducted. SEM images of the AuNPs 
synthesized using Method One revealed different sizes and shapes of gold  
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Figure 30 Size/ intensity histograms of gold nanostructures 
Size/ intensity histograms of gold nanostructures synthesized from 0.1mM (A), 0.5Mm (B), 1mM 
(C) aqueous AuCl4- by live ivy shoots at room temperature. Size/ intensity histograms of gold 
nanoparticles synthesized by different ivy rootlet extract solutions I (D), II (E), III (F) and IV (G). 
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nanostructures produced by the varying HAuCl4 concentration (Figure 31A-C). 
Fig. 6A showed relatively uniform, spherical gold nanoparticles with sizes ranging 
from 10 to 100 nm, formed from 0.1 mM HAuCl4. The SEM images of gold 
nanoparticles synthesized using 0.5 mM HAuCl4 showed that most of the AuNPs 
had a spherical morphology, with a narrow size range of around 100 nm. At 1 
mM HAuCl4, the AuNPs formed were heterogeneous with triangular, hexagonal, 
and spherical morphologies (Figure 31C). EDS was run simultaneously and 
determined that the nanoparticles were Au (Figure 31D). 
Similar to the results obtained from the AuNPs synthesized using Method One, 
SEM images of AuNPs formed using Method Two revealed micro- or nano- 
crystals in all samples (Figure 31E-H). In solution I, spherical nanoparticles with 
a size range of 20-50 nm size were observed, with no other shapes of 
nanocrystals (Figure 31E). In solution II, nanoplates, nanorods, and spherical 
nanoparticles were observed (Figure 31F). In solution III, nanocrystals with sizes 
larger than 50 nm dominated, with triangular nanoplates also appearing (Figure 
31G). Analysis of solution IV revealed the presence of predominately triangular 
nanoplates, with only a small number of spherical nanoparticles and nanocrystals 
with small diameters (Figure 31H). 
Protein and polysaccharide concentration of the reaction solutions 
 
Using a BCA kit, the concentration of protein present in the reaction solution for 
Method One was determined to be 1.45 µg/ml. However, the protein 
concentration of the adventitious root extract without dialysis in Method Two,  
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Figure 31 SEM images of gold nanostructure synthesized in 0.1mM, 0.5mM, 1mM aqueous 
AuCl4- by live ivy shoots at room temperature. 
SEM images of gold nanostructure synthesized in 0.1mM (A), 0.5mM (B), 1mM (C) aqueous 
AuCl4- by live ivy shoots at room temperature, (D) EDX of the treated sample. SEM micrographs 
of gold nanoparticles synthesized by different ivy rootlet extract solutions I (E), II (F), III (G) and IV 
(H). (All scale bar= 100nm)  
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prior to reaction with HAuCl4, was found to be 1815.3 µg/ml. After reaction with 
HAuCl4, using Method Two, only 340.1 µg/ml remained in the supernatant, an 80% 
decrease compared to the starting concentration. Unlike the trend in protein 
concentration between the two methods, the DMMB assay determined that the 
concentration of proteoglycan in the reaction solution using Method One was 
4.675 µg/ml, while the concentration for Method Two was 2.33 µg/ml.  
Intracellular uptake of synthesized AuNPs 
 
To test whether the AuNPs produced by both methods could be transported into 
cells for potential biomedical applications, a Cytoviva™ condenser mounted to a 
Nikon Eclipse microscope was used. Briefly, various AuNPs obtained from both 
methods were incubated with DMEM containing 10% serum for 24 hours, 
followed by centrifugation at 14,000 rpm and three washes of PBS. Microscopic 
analysis showed the internalization of the AuNPs into MC3T3 cells. Using the 
Cytoviva™ condenser, AuNPs were distinct from organelles due to their 
scattering properties, which make them appear scarlet or yellow in color (Figure 
32). The control group without nanoparticles had no internal particulates, 
whereas the experimental samples displayed scarlet or yellow nanoparticles. 
This confirmed that the AuNPs synthesized in this study can be transported 
across the cell membrane, similar to AuNPs produced by other methods used for 
cancer therapy [182]. Previously, AuNPs have been proven to have great 
potential in drug delivery, cancer therapy and bio-imaging applications [183]. It is 
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Figure 32 Dark-field microscopy images of Au NPs synthesized from HAuCl4 
Dark-field microscopy images of Au NPs synthesized from 0.1 mM HAuCl4 (B), 0.5 mM HAuCl4 
(C), 1 mM HAuCl4 (D) in MC3T3 cells respectively. (A) is the control group, without AuNPs. 
MC3T3 cell incubated with gold nanoparticles from solution II (E), and gold nanocrystals from 
solution III, IV (F).  
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conceivable that proteins, polysaccharides and other small molecules would 
provide a robust coating around gold nanoparticles to prevent aggregation. The dark 
field images demonstrated that our synthesized AuNPs using both methods could be 
easily taken up by the cells.  
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Discussion  
Two methods for the synthesis gold nanoparticles using English ivy were 
developed. In Method One, a system was developed for the sustainable 
synthesis of AuNPs from the addition of aqueous HAuCl4 to actively growing 
English ivy shoots. The resulting AuNPs were collected from the culture medium 
every 24 hours, and fresh HAuCl4 solution was added to replenish the media. In 
Method Two, AuNPs were synthesized using four fractions of adventitious root 
extract separated by molecular weight using dialysis. When comparing the two 
methods at the same concentration of HAuCl4, 0.5 mM, both methods 
demonstrated the ability to form predominately spherical nanoparticles. However, 
the nanoparticles formed using Method Two, Solution I, showed a much smaller 
nanoparticle size compared to Method One at the same concentration. When 
Solutions II-IV were used, more diverse nanoparticle morphology was observed, 
with nanotriangles representing the dominant morphology. A similar trend was 
observed using Method One, where increasing concentrations of HAuCl4 led to 
the formation of nanotriangles, and fewer spherical nanoparticles. Considering 
that spherical nanoparticles are the most sought after morphology for biomedical 
applications, it would seem that the nanoparticles formed using Method One at a 
concentration of 0.5 mM HAuCl4, or Method Two using Solution I would be the 
best choices for green synthesis of spherical nanoparticles. In addition to the 
shape of synthesized AuNPs, the size of nanoparticles is also important in 
biomedical applications, and in general, the AuNPs formed from Method Two 
(Figure 30 D-G) were smaller than those formed from Method One (Figure 30 A-
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C). While the size and shape of AuNPs necessary for a given application may 
dictate the choice of methods used for synthesis, other factors should be 
considered when comparing the two synthesis methods developed in this study. 
Using Method One, a significant amount of nanoparticles was synthesized over 
an extended period of time by simply replenishing HAuCl4 in the growth media of 
the ivy shoots. In this study, we were able to generate sustained nanoparticle 
production over a period of 30 days using the same shoots. Thus, Method One 
does not require a large input of raw plant materials, since a single batch of 
shoots can be sustained for over a month. This represents an economically 
favorable strategy, compared to strategies that require the destruction of the 
plant tissue for the formation of an extract, such as that described in Method Two. 
However, since the only control parameter that can be varied in Method One is 
the concentration of HAuCl4, it is expected that there would be less control over 
modifying this method for the generation of a particular AuNP size or morphology. 
In essence, the metabolic nature of the shoots will dictate the size and shape of 
the nanoparticles. Using Method Two, it is possible to more finely tune the 
synthesis of the AuNPs. For example, in Method Two, temperature, pH, extract 
concentration, and HAuCl4 concentration can be varied to more finely control the 
formation of specific AuNP sizes and morphology. In addition, while Method One 
represents a sustainable method, the AuNPs are collected every 24 hours, 
whereas in Method Two, the AuNPs can be collected in a matter of hours. The 
more rapid synthesis of AuNPs using Method Two may lead to the formation of a 
greater number of nanoparticles per unit time than Method One. As mentioned 
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earlier, since the extract formed using Method Two destroys the plant tissue in 
the formation of the extract, there would be an associated cost with this method 
over Method One. As such, the choice of green synthesis method depends on a 
variety of factors, with the ultimate choice being left to the user.    
Another difference between the two methods is the potential biomolecules 
involved in the formation of the nanoparticles. The synthesis of gold 
nanoparticles in Method One could be achieved through two different routes. 
They can be synthesized directly in water, or can be formed in live shoots then 
released back to the water through the vascular system present in the stem. To 
investigate how these gold nanoparticles formed, 50 ml deionized water without 
HAuCl4 was placed into the GA7 box with live ivy shoots for 24 hours. The water 
was then removed from the box and mixed with different concentrations of 
HAuCl4 outside the culture system. It was observed that the AuNPs were slowly 
formed in solution, as evidenced by the gradual color change. The UV-Vis 
spectra were used to confirm the formation of gold nanoparticles (Figure 33 A). 
The broad SPB in the spectra resulted from the formation of large anisotropic 
particles. It was also observed from the SEM image of polydispersed AuNPs 
synthesized at 1 mM aqueous HAuCl4 solution (Figure 33 B). From these results, 
we hypothesized that biomolecules or small chemicals were continuously 
released into the culture water through ivy stems, which are responsible for 
reducing, stabilizing and shape-controlling agents for AuNPs synthesis. 
In Method Two, the ivy rootlet extract was separated into four fractions using 
different MWCO dialysis bags. Most polyphenols are in the size range of 0.5- 
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Figure 33 UV-Vis spectra of gold nanoparticles synthesized using different concentration 
of HAuCl4 solution  
UV-Vis spectra of gold nanoparticles synthesized using different concentration of HAuCl4 solution 
(1mM, 0.5mM, 0.2mM, 0.1mM) with DI water derived from ivy culture system. B, SEM image of 
gold nanoparticles synthesized at 1mM HAuCl4 solution with DI water derived from ivy culture 
system. (the scale bar= 100nm) 
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4kD, and thus would be contained in solution I or II. Based on the size range, 
solution III was expected to contain the majority of biopolymers, such as 
polysaccharides and proteins, while solution IV may contain protein complexes 
and large macromolecules, such as glycoproteins or proteoglycans. The 
synthesis of gold nanoparticles by these four different solutions implied that 
molecules in different size ranges could individually and independently contribute 
to the synthesis of gold nanoparticles. To confirm the chemical components 
possibly involved in the synthesis process, the BCA protein assay, and 
proteoglycan assay were used to determine protein and proteoglycan 
concentrations. The results showed that both proteins and GAGs were available 
in the reaction solution of two methods. The concentration of proteins was much 
lower in Method One (1.45 µg/ml) than the extract solution without treatment in 
Method Two (1815.3 µg/ml), while the polysaccharide concentration in Method 
One (4.675 µg/ml) was twice that of Method Two (2.33 µg/ml). Considering that 
proteins secreted from the shoots of English ivy will be minimal, and that Solution 
I from Method Two, where most proteins will have been removed, generated the 
most uniform spherical nanoparticles, it is expected that other molecules are 
driving the formation of the AuNPs. Due to the comparably larger size of proteins, 
it is not surprising that the nanoparticles formed using Solutions II-IV of Method 
Two have increasingly larger size distributions, most likely due to the adsorption 
of proteins to the nanoparticle surfaces.  
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Conclusion 
Two methods for the green synthesis of AuNPs using English ivy have been 
developed. Method One is a simple, sustainable synthesis system for AuNP 
production using actively growing English ivy shoots. This system allows 
continuous synthesis of gold nanoparticles in water with the addition of HAuCl4 
solution.  Compared to other plant-based synthesis methods for metal 
nanoparticles, the newly established system described in Method One does not 
require the preparation of plant extracts, or complicated isolation from live plants, 
thus representing a significant advancement in plant-based green manufacturing 
of metal nanoparticles. In Method Two, the facile synthesis of AuNPs from 
different molecular weight fractions of adventitious root extract was examined. 
Using different molecular weight ranges of the extract, AuNPs could be tuned to 
generate different shapes and sizes of AuNPs. The synthesized biocompatible 
AuNPs obtained from both methods could easily enter into MC3T3 cells, making 
them attractive candidates for bio-imaging, cancer therapy, and drug delivery.  
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CHAPTER V  
ONE-STEP SYNTHESIS OF DENDRITIC GOLD NANOFLOWERS 
WITH HIGH SURFACE-ENHANCED RAMAN SCATTERING (SERS) 
PROPERTIES 
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Introduction 
Gold nanostructures have drawn increasing interest due to their tunable 
morphology and promising optical as well as electronic properties for biomedical 
applications [45, 51, 184]. Especially in recent years, gold nanoparticles have 
demonstrated great potential in molecular imaging and sensing for disease 
diagnosis and therapy [185]. The majority of gold nanostructure research has 
focused on how the changes in size and shape of the nanostructures may 
influence their properties for applications in cancer therapy [186-188]. To 
enhance surface properties of gold nanostructures, efforts have been made into 
the development of nanostructures with unique morphology. Of particular interest 
is that gold nanopaticles have shown promise in bioimaging and biosensing [185]. 
Colloidal gold nanoparticles have been proposed as therapeutic nanocarriers for 
cancer treatment [186]. The most significant advance in increasing surface 
morphology of gold nanoparticles is the discovery of gold nanoflowers [189]. 
Gold nanoflowers are specialized gold nanoparticles with large amounts of highly 
branched tips that give the overall appearance of a flower. Nanomorphology of 
the highly branched surfaces with tips often leads to the formation of sharp peaks 
and valleys, which are potential ―hot spots‖ for localized near-field enhancements 
[45, 50, 51]. The highly branching nanostructures can drastically increase the 
ratio of total surface to volume. These factors could potentially lead to the 
enhancement of the Raman scattering on the highly branched gold 
nanostructures [52, 53]. Therefore, compared with smooth surfaces, highly 
branched surfaces (such as dendrites, multi-pods, and nanoflowers) have a 
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greater potential for SERS based bioimaging and biosensing. For these reasons, 
studies have been conducted on the use of gold nanoflowers in bioimaging[45], 
biosensing[190], drug delivery and tissue engineering [191]. Despite the promise 
of gold nanoflowers, it remains a major challenge to repeatedly synthesize the 
unique nanostructures with low cost.  
 Currently, several  synthetic methods have been proposed to synthesize 
branched metal nanostructures and gold nanoflowers [188, 192-194], including 
seed-mediated growth approaches, such as using CTAB, ascorbic acid [195],  
and one-pot methods using  polyvinylpyrrolidone (PVP) [196], and tris base 
(TB)[197] . Some one-step synthesis approaches have been effective at 
producing thin gold nanoplates or multipods with a limited number of sharp tips, 
but have not been proven effective at the formation of highly branched gold 
nanoflowers [51, 189, 198, 199]. Seed-growth approach has been used to 
synthesize gold nanoflowers; however, concerns remain over repeatability of the 
method. For instance, size and shape of the gold nanoflowers synthesized by the 
two-step seed-mediated growth often depend on the facets of seed molecules, 
whose mechanism currently is not well understood [188, 193]. As such, it is 
difficult to control the formation of highly branched gold nanoflowers using most 
current methods. In addition, the multiple steps and the use of hazardous 
chemical reactants remains a major concern for biomedical applications [200]. 
Thus, the development of highly branched (more sharp tips) gold nanoparticles 
with biocompatible, low-cost, eco-friendly, and well-defined hierarchical structure 
is still a daunting challenge. 
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It is well-known that the oxidation of dopamine by AuCl4- could contribute to the 
formation of gold nanoparticles [201]. In this communication, a one-step 
approach for synthesizing gold nanoflowers (Au NFs) with multiple tips and 
dendritic structures is proposed by using dopamine. Briefly, Au NFs synthesized 
by combining HAuCl4 with dopamine hydrochloride in a rapid one-step reaction. 
The method uses dopamine, a natural neurotransmitter, as both the reducing and 
shape-directing agents, which is environmental friendly. Additionally, the Au NFs 
synthesized using this method have increased biocompatibility, due to the 
coating of the Au surface with an organic molecule that is normally present in 
mammalian cells. In order to further control the synthesis and morphology of the 
Au NFs, the effects of variations in reactant concentration, pH and temperature 
are discussed. Upon completion and tuning of the Au NF formation process, 
SERS activities and intracellular uptake of the Au NFs by human lung A549 
cancer cells and mouse melanoma B16BL6 cells are present.  
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Results and Discussion 
In the proposed experiment, Au NFs were synthesized by mixing 1mM HAuCl4 
with 5mM dopamine hydrochloride with the original pH of 2.5 and vortexing for 1 
min at room temperature. The color of the solution immediately changed from a 
light yellow to a dark orange, indicating the reduction of Au (III) to Au (0) [202]. 
The Au NFs were collected by centrifugation at 16,873 × g for 5 min followed by 
three washes using DI water. As shown in Figure 1, the synthesized flower-like 
particles exhibited multiple tips with dendritic structures. The Au NFs were 
dispersed with the average size in the range of 310-820 nm (Figure 34 A), and 
were comprised of numerous dendritic tips of 60-240 nm in length (Figure 34 B). 
The average hydrodynamic size of the nanoflowers in solution was approximately 
630nm characterized by dynamic light scattering (DLS). The average zeta 
potential of the Au NFs was about -27.1 mV, indicating moderate stability of the 
Au NFs in solution. Furthermore, the crystal structure of the Au nanostructure 
was confirmed using X-ray diffraction (XRD). As shown in Figure 35, the XRD 
pattern of the Au NFs showed five peaks assigned to diffraction from the (111), 
(200), (220), (311), and (222) planes of face-centered-cubic (fcc) gold, which 
indicated the pure and well-crystallized gold [203]. 
The formation of the Au NFs over time was followed to determine how quickly 
they were formed, and the effect of increased reaction time on their formation. 
The reaction and evolution of the Au NFs were followed by time-dependent UV-
vis spectroscopy and SEM. A decrease in intensity of the band at 390 nm, which 
is a characteristic band for dopamine-o-quinone,[204] indicated that the  
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Figure 34 SEM images of the Au NFs obtained from an aqueous solution of HAuCl4 and 
dopamine  
SEM images of the Au NFs obtained from an aqueous solution of HAuCl4 (1mM) and dopamine 
(5mM). (A) The Au NFs had the average size ranging from 310-820 nm. Insert picture (B) is the 
enlarged image of the Au NFs, showing multiple tips with dendritic structures with the length of 
approximately 60-240 nm. 
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Figure 35 XRD pattern obtained from a thin film of Au NFs on a glass substrate. 
The Au NF solution was on a glass substrate to obtain a smooth plane surface, and the diffraction 
pattern was recorded over a 2θ range of 35˚ - 85˚. The sharp reflections at 38.2˚, 44.3˚, 64.7˚, 
77.6˚ and 81.8˚ correspondingly index as (111), (200), (220), (331) and (222), indicating 
characteristics of face-centered cubic (fcc) gold.  
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dopamine was reacting with the gold substrate (Figure 36). With the decrease of 
the dopamine-o-quinone peak, a shoulder began to form at ~510 nm, indicating 
the time dependent formation of the dendritic gold nanoparticles (Figure 36). 
Previous studies analyzing the UV-vis formation of dendritic gold nanostructures 
reported a similar trend, with the emergence of a broad peak from 500-600 nm, 
which was correlated with the gold nanostructures[205]. As shown in Figure 37 
A-D, the possible development of reaction and the evolution of Au NFs were 
proposed as follows.  First, the nanocrystals formed through the nucleation of 
gold, followed by equilibrium of gold nanocrystal growth, which is most likely via a 
Volmer-Weber mechanism [206]. Briefly, the stacked aggregations of small gold 
nanoparticles (roughly 10-50 nm) build up the tip of gold dendrites, and then 
AuCl4- ions and dopamine in solution are continuously captured by the tips via 
migration and diffusion [207]. The oriented attachment process could contribute 
to the formation of gold dendrites by the addition of new gold nanoparticles on 
the surface[207]. Then, several dendritic nanocrystals with different sizes were 
generated and their centers were randomly positioned in a spherical core. Finally, 
successive agglomerations of large amounts of dendritic tips around the core 
form flower-like nanostructures. Considering the possible growth processes of 
the Au NFs, we hypothesized that the concentration of the reactants (HAuCl4 and 
dopamine) might affect the size and morphology of Au NFs. To validate this 
hypothesis, the concentration of dopamine was decreased from 5 mM to 1 or 0.5 
mM, while keeping the concentration of gold precursor (HAuCl4) constant as 
1mM. As shown in Figure 37 A-B, irregular gold nanoparticles were formed with  
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Figure 36 Time-dependent UV-vis spectra of reaction between HAuCl4 and dopamine.  
Time-dependent UV-vis spectra of reaction between HAuCl4 (1mM) and dopamine (5mM). The 
decreasing band at 390 nm is the characteristic band for dopamine-o-quinone. An increasing 
shoulder at ~510 nm indicates the formation of dendritic gold nanoflowers, similar to previous 
studies of dendritic gold nanostructures. 
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Figure 37  SEM images of the proposed mechanism for the formation of Au nanoflowers 
SEM images of the proposed mechanism for the formation of Au nanoflowers (from A to D). First, 
several dendritic nanoparticles with different diameter were generated (A-B) and their centers 
were randomly positioned in a spherical space (C). After the generation of the primary structure, 
the inner core of the nanoflowers was formed by adding new dendritic nanoparticles around their 
center (D).  
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Figure 38 SEM images show the size and morphology of Au NFs affected by the 
concentration of the reactants (HAuCl4 and dopamine). 
SEM images show the size and morphology of Au NFs affected by the concentration of the 
reactants (HAuCl4 and dopamine). Au nanoparticles obtained from an aqueous solution of (A) 
HAuCl4 (1mM) and dopamine (0.5mM), (B) HAuCl4 (1mM) and dopamine (1mM). The images 
show irregular Au nanoparticles were formed with the size ranging from 50 to 300 nm. Au 
nanoparticles obtained from an aqueous solution of (C) HAuCl4 (0.25mM) and dopamine (5mM), 
(D) HAuCl4 (0.5mM) and dopamine (5mM). Random gold nanoparticles were observed, and few 
irregular flower-like nanostructures appeared with the aggregation of several small nanoparticles. 
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the size ranging from 50 to 300 nm. These gold nanoparticles were devoid of the 
sharp tips observed in the Au NFs. According to a previous study [201], gold 
nanoparticles also formed with the HAuCl4 concentration at 0.2 mM in the 
presence of lower concentrations of  dopamine ranging from 2.5 µM to 0.02 mM. 
These findings indicate that low concentration of dopamine leads to the rough 
gold nanoparticles formation rather than flower-like gold nanostructures with 
sharp tips. However, when the dopamine concentration was increased to 5 mM, 
flower-like nanostructures were formed. Similar to the effect of changes in 
dopamine concentration, changes in the starting HAuCl4 concentration led to 
observable changes in size and morphology. When the HAuCl4 concentration 
was decreased from 1 mM to 0.5 mM and 0.25 mM, gold nanoparticles were 
formed along with irregular Au NFs (Figure 38 C-D). These Au NFs appeared 
with the aggregation of multiple smaller nanorods or spherical nanoparticles, 
while they were devoid of sharp tips and dendritic structures. In this study, 
dopamine likely acted as both the reducing and capping agents, attributing to the 
formation of Au NFs. To study the surface capping effect of dopamine, the 
Fourier transform infrared spectroscopy (FTIR) was used to characterize the pure 
dopamine and the synthesized Au NFs. As shown in Figure 39, some strong 
absorption features such as 1342 cm-1 (due to CH2 bending vibration), 1320 cm-
1 (due to C-O-H asymmetry bending vibration), 1190 cm-1 (C-O symmetry 
vibration) in dopamine hydrochloride spectrum all disappeared in the Au NF 
spectrum [208]. The appearance of peaks at around 1455 and 1410 cm-1 in Au 
NF spectrum was due to the formation of the dopaminechrome [209]. The FTIR  
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Figure 39 FTIR spectra of dopamine and synthesized Au NFs. 
Some strong absorption features such as 1342 cm-1 (due to CH2 bending vibration), 1320 cm-1 
(due to C-O-H asymmetry bending vibration), 1190 cm-1 (C-O symmetry vibration) in dopamine 
hydrochloride spectrum all disappeared in the Au NF spectrum. Instead, the appearance of peaks 
at around 1455 and 1410 cm-1 in Au NF spectrum was due to the formation of the 
dopaminechrome.  
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spectra provided evidence that the oxidation of dopamine might reduce Au ions 
to Au (0), and oxidative dopamine was absorbed on the Au NF surface.  
Considering the effect of reactant concentration on Au NF synthesis, other 
reaction conditions, including pH, and temperature were also investigated. It was 
found that the tip length of the nanoflowers decreased with increasing pH values. 
2N NaOH solution was used to regulate the pH value to be 3.5, 7.0, 8.5, and 9.0. 
When the pH increased to 3.5, smaller nanoflower-like gold nanoparticles with 
shorter tips in the length of around 20-80 nm were observed under SEM (Figure 
40 A). As the pH value increased beyond 7.0, globular nano- and microparticles 
were formed as opposed to the flower like structures observed at pH 3.5 (Figure 
40 B). We hypothesize that the reason for the above phenomenon is due to the 
increase of the oxidation rate of dopamine through increasing the pH values [201, 
210], the chance for dopamine to cap and reduce the Au ions will be significantly 
reduced. Another parameter expected to alter the size and morphology of the Au 
NFs is the reaction temperature, since it affects nucleation, diffusion, and growth 
rates [211]. To determine the effect of reaction temperature, reactions of 1 mM 
HAuCl4 and 5 mM dopamine were maintained at different temperatures (20 °C; 
40°C; 60 °C; 80 °C; 100 °C) with the pH value of 2.5. Interestingly, the reaction 
temperature did not affect the size and morphology of the Au NFs (Figure 40 C-
F); however, with the increase of the reaction temperature, the color of the 
reacting solution was changed quickly, indicating the faster growth rate of the Au 
NFs.  
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Figure 40  SEM images of Au NFs obtained from an aqueous solution of HAuCl4 and 
dopamine 
SEM images of Au NFs obtained from an aqueous solution of HAuCl4 (1mM) and dopamine 
(5mM) at pH= 3.5 (A) and pH= 8.5 (B). And Au NFs obtained from an aqueous solution of HAuCl4 
(1mM) and dopamine (5mM) with the original pH value of 2.5 at different temperature: 40˚C (C), 
60˚C (D), 80˚C (E) and 100˚C (F). They showed at different reaction temperatures, the size and 
morphology of Au NFs did not have significant change.   
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Based on the above results, we may modify the Au NF structures through 
regulating concentration of the reactants, and the pH values.  
SERS of gold nanoparticles and nanostructures has been regarded as a new 
optical spectroscopic analysis technique for sensitive detection of biomolecules 
in medicine [212, 213]. Since the weak spontaneous Raman scattering, colloidal 
gold nanoparticles has been well documented, where the increase in surface to 
volume ratio often leads to an enhanced SERS by 1014-1015 folds [45]. To 
demonstrate the importance of the Au NFs synthesized in this study, we have 
analyzed the surface enhanced Raman scattering (SERS) of the Au NFs, and 
their potential for intracellular delivery. In previous work, the optimum size range 
of spherical gold nanoparticles for SERS was determined to be 20-70 nm [214]. 
Considering the small size of these gold nanoparticles, to further increase the 
SERS signals, it is necessary to alter the surface morphology to increase the 
surface to volume ratio. As such, studies have demonstrated that highly 
branched flower-like nanostructures can further enhance SERS by 10 times [45]. 
Furthermore, gold multipods with a limited number of tips (less than 10) or 
multiple tips without complex structures have been shown to create large 
electromagnetic field enhancements at the particle tips, with the efficiency of 
SERS effects related to the number of tips [45, 51, 188]. Based on this data, and 
the highly branching dendritic tips present on the Au NFs synthesized in this 
study, we hypothesize that this complex nanostructure may be used for SERS 
applications. To confirm this hypothesis, rhodamine 6G (Rh6G), a standard 
SERS probe molecule, was used to investigate the SERS capability of the Au 
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NFs. As a control, spherical gold nanoparticles (Au NPs) with a diameter from 10 
to 100 nm were synthesized using a previously defined method [160]. Note that 
the control Au NPs are within the optimum size range for SERS applications. The 
typical SERS spectra of Au NFs and Au NPs with adsorbed Rh6G are presented 
in Figure 41. For the typical peaks (1315 cm-1, 1345 cm-1, 1450 cm-1, 1515 cm-
1) in the Raman spectra, Au NFs showed much stronger enhancement of the 
SERS effect than gold nanoparticles. The significant enhancement might be due 
to the large amount of sharp tips on the surface of Au NFs that potentially act as 
―hot spots‖ [45]. Additionally, numerous tiny sharp tips or cavities on the dendritic 
structures may also act as ―hot spots‖ [215], which attribute to achieve an double-
enhanced SERS effect. 
Due to the enhanced SERS of Au NFs, the combination of bio-imaging and 
delivery using the Au NFs were evaluated. Considering that biocompatibility is a 
major concern for biomedical applications, the cytotoxicity of the Au NFs was 
tested in A549 human lung tumor cells, and B16BL6 mouse melanoma cells. 
Both cells were treated with Au NFs in different concentrations (0.128-400 µg/ml) 
for 48 h and then the cell viability was analyzed using the MTT assay. As shown 
in Figure 42 A-B, the cell viability in both cell lines was > 85% with the Au NF 
concentrations as high as 400 µg/ml. The low cytotoxicity of the Au NFs 
demonstrates a similar biocompatibility with gold nanoparticles often used in 
biomedical applications, thus validating the good biocompatibility of the Au 
NFs[216, 217]. Furthermore, the intracellular uptake of the nanoflowers in tumor 
cells was tested using dark field microscopy. As shown in Figure 42 C-F,  
  149 
 
Figure 41 SERS spectra of Rh6G adsorbed on Au NFs and Au NPs, pure Rh6G as a control. 
SERS spectra of Rh6G adsorbed on Au NFs (Black) and Au NPs (Red), pure Rh6G as a control 
(Blue). The concentrations of Rh6G in all samples were 5×10-5 M. The increased intensities of 
bands at 1315 cm-1, 1345 cm-1, 1450 cm-1, 1515 cm-1 on Au NFs compared with Au NPs 
indicated the Au NFs exhibited strong surface-enhanced Raman scattering effects. 
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Figure 42 Survival histograms for A549 and B16BL6 cells exposed to AuNFs. 
Survival histograms for A549 (A) and B16BL6 (B) cells exposed to Au NFs with various 
concentrations for 48 hours. Cell viability was measured by the MTT assay. Dark field images of 
A549 cells treated without nanoflower (C) and with Au NFs (D); B16BL6 cells treated without 
nanoflower (E) and with Au NFs (F). The Au NFs were incubated with cells for 4 hours at room 
temperature. The bright spots in B and D suggested the Au NFs were internalized in cancer cells. 
The scale bar indicates 10µm. 
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compared with the control group (without Au NF treatment) (Figure 42 C, E), 
more Au NFs entered into the cells (Figure 42 D, F). It is likely that the Au NFs is 
internalized by cancer cells through endocytosis, which is similar with other 
synthesized gold nanoparticles[218, 219]. These results suggest that the Au NFs 
could be proposed as active tags combined with specific biomolecules for in vitro 
detection. 
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Conclusion 
 In summary, a one-step approach for the synthesis of well-defined hierarchical 
Au NFs with low cost and eco-friendly has been developed. The highly branched 
Au NFs exhibited a strong SERS effect, due to the unique surface morphology 
with a large amount of sharp tips and dendritic structures. Furthermore, the Au 
NFs can be readily internalized by cancer cells along with promising 
biocompatibility. The above features make the Au NFs a unique candidate for 
bio-imaging, biosensors, and other biomedical applications.  
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CHAPTER VI  
FUTURE PERSPECTIVES 
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Although nature based nanoparticles are generally biocompatible and less 
environmental toxicity associated with their production, there are still many 
aspects of their development that need to be improved. To be effective 
nanoparticles must maintain in vivo biostablity, circulate freely through the 
vascular systems of patients, and target specified cell types and organelles. 
Once they are produced, nature based nanoparticles must be modified and 
linked to small peptides, antibodies, or proteins to achieve particle stealthing, 
cellular targeting and organelle targeting.   
 
Nanoparticle shields 
When nanoparticles are administered systemically and circulate in the blood 
stream, sinusoids in the spleen filter the nanoparticles, and target them for 
removal via the reticuloendothelial system (RES) [220]. Nanoparticles bind to 
specific proteins of the RES cells [221]. Immunoglobulin and complement 
proteins are the major contributors to the recognition of the nanoparticles by the 
RES cells. The cells, which are macrophages will activate complement and 
induce hypersensitivity reactions [222]. The selective removal of the 
nanoparticles by the RES cells can be reduced by changing the characteristics of 
the nanoparticles’ surface to render them more hydrophilic and neutralize the 
nanoparticle surface charge. The strategy covertly being investigated involve 
linkage of PEG to the surface of the nanoparticle to slow down the process of the 
RES cells binding to the nanoparticles [223]. Recently, Furumoto found that 
particles covalently bound with the albumin to their surface circulate longer 
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compared to the naked or PEGylated particles [224]. In another study by binding 
the nanoparticles to albumin, Furumoto was able to improve pharmacokinetic 
and pharmacodynamics properties of the doxorubicin-containing particles 
compared to PEGylated particles. Chemical modification of nature based 
nanoparticles with albumin to gain an extended circulation time and better 
stability.  
 
Cellular targeting 
Drug-carrying nanoparticles circulating in the blood stream need to be directed to 
specific target cells with minimal off-target effects. Many targeting mechanisms 
have been examined, utilizing both positive and negative targeting methods. 
Negative targeting, takes advantage of the fact that nature based nanoparticles 
accumulate in tumors due to enhanced permeability and retention effects, which 
is the result of the leaky, underdeveloped tumor vasculature that allows 
macromolecules to accumulate in the tumor [225]. Positive targeting of specific 
cells, involves the use of antibodies, aptamers, peptides and small molecules 
which bind to specific receptors. Most rapidly dividing cancer cells overexpress 
transferrin and folate receptors [226]. Unfortunately, these receptors are 
expressed to some degree on other non-target cells, resulting in off-target effects. 
The use of multi-specific antibodies to target the unique molecular marks on the 
cancer stem cells (CSCs), the source of the cancer, will alleviate the problems.   
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Cancer stem cells are a self-renewing population that express high ATP-
binding cassette transporters (ABC transporters), which tend to export the 
chemotherapy agents, making the cells highly drug-resistant [227]. If CSCs leave 
their tissue barriers and circulate in the blood stream, they are able to 
metastasize and the cancer spreads. CSCs are characterized by their self-
renewing ability and tumor regenerative ability. CSCs have distinct cell surface 
markers, which are different from the bulk of the tumor. In the breast cancer for 
example, breast cancer cells that express high levels of CD44 and low or 
undetectable levels of CD24 (CD44+/CD24-/low) are resistant to chemotherapy 
and have a significantly higher tumor generating ability compared to cells without 
these characteristics [228]. Therefore, by linking muti-specific antibodies, which 
are unique to certain CSCs, to nature based nanoparticles, an effective and 
highly selective method, can be developed for cancer treatment.   
 
Organelle-specific targeting 
Once the carrier nanoparticles enter a cell, the treatment efficiency is still heavily 
dependent on the ability of the carrier to deliver the drug to the site of action. If 
nanoparticle drug complex cannot successfully escape from the harsh 
endolysosome, it will be degraded. To enhance the endosomal escape, positively 
charged nanoparticles will be developed, which will mediate the rupture of the 
endosome following entry [229]. Subsequent to endosomal escape, the 
nanoparticles will be free to deliver DOX to nucleus generate DNA 
topoisomerase II mediated lesions in nuclear DNA, leading to apoptosis [230]. 
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DOX has been used to treat many tumor types, but often its delivery has been 
problematic due to the drug-resistant cancer cells actively effluxing the drug out 
of their nuclear membranes [231]. Recently, a mitochondrially targeted version of 
mtDOX has been developed which has a peptide that targets mitochondria. It has 
been proven to be highly effective even in cell lines with an overexpressed efflux 
pump [232]. Nature based nanoparticle drug carriers; with a substitution of 
mtDOX in place of the original DOX therefore have the potential to provide a 
highly efficient drug delivery system targeting the drug-resist cancer cells.  
 
In the development of nanoparticles that are site specific, efficient and of low 
toxicity, nanoparticle stealthing, cellular targeting, and organelle targeting must 
be considered. Nature based nanoparticles will be modified with albumin to 
reduce the RES effects, providing greater stability in the blood stream. Linkage of 
the nanoparticles to multi-specific antibodies will provide a means of targeting the 
CSCs to eliminate the source of the cancer. The DOX currently being used will 
be replaced by the mitochondrial targeting DOX to achieve better efficiency, 
especially in the drug-resist cancer cells. There is no single combination of 
nanoparticle modifications that will result in a perfect biomedical nanoparticle, but 
this is one more step in the right direction. It takes a lot of small steps to reach 
the final destination – the control and eradication of human disease.  
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